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A B S T R A C T
Background
Missed hospital outpatient appointments is a commonly reported problem in healthcare services around the world; for example, they cost
the National Health Service (NHS) in the UK millions of pounds every year and can cause operation and scheduling diHiculties worldwide. In
2002, the World Health Organization (WHO) published a report highlighting the need for a model of care that more readily meets the needs
of people with chronic conditions. Patient-initiated appointment systems may be able to meet this need at the same time as improving
the eHiciency of hospital appointments.
Objectives
To assess the eHects of patient-initiated appointment systems compared with consultant-led appointment systems for people with chronic
or recurrent conditions managed in secondary care.
Search methods
We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, and six other databases. We contacted
authors of identified studies and conducted backwards and forwards citation searching. We searched for current/ongoing research in two
trial registers. Searches were run on 13 March 2019.
Selection criteria
We included randomised trials, published and unpublished in any language that compared the use of patient-initiated appointment
systems to consultant-led appointment systems for adults with chronic or recurrent conditions managed in secondary care if they reported
one or more of the following outcomes: physical measures of health status or disease activity (including harms), quality of life, service
utilisation or cost, adverse eHects, patient or clinician satisfaction, or failures of the 'system'.
Data collection and analysis
Two review authors independently screened all references at title/abstract stage and full-text stage using prespecified inclusion criteria.
We resolved disagreements though discussion. Two review authors independently completed data extraction for all included studies. We
discussed and resolved discrepancies with a third review author. Where needed, we contacted authors of included papers to provide more
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information. Two review authors independently assessed the risk of bias using the Cochrane EHective Practice and Organisation of Care
'Risk of bias' tool, resolving any discrepancies with a third review author. Two review authors independently assessed the certainty of the
evidence using GRADE.
Main results
The 17 included randomised trials (3854 participants; mean age 41 to 76 years; follow-up 12 to 72 months) covered six broad health
conditions: cancer, rheumatoid arthritis, asthma, chronic obstructive pulmonary disease, psoriasis and inflammatory bowel disease.
The certainty of the evidence using GRADE ratings was mainly low to very low. The results suggest that patient-initiated clinics may
make little or no diHerence to anxiety (odds ratio (OR) 0.87, 95% confidence interval (CI) 0.68 to 1.12; 5 studies, 1019 participants; low-
certainty evidence) or depression (OR 0.79 95% CI 0.51 to 1.23; 6 studies, 1835 participants; low-certainty evidence) compared to the
consultant-led appointment system. The results also suggest that patient-initiated clinics may make little or no diHerence to quality of
life (standardised mean diHerence (SMD) 0.12, 95% CI 0.00 to 0.25; 7 studies, 1486 participants; low-certainty evidence) compared to
the consultant-led appointment system. Results for service utilisation (contacts) suggest there may be little or no diHerence in service
utilisation in terms of contacts between the patient-initiated and consultant-led appointment groups; however, the eHect is not certain
as the rate ratio ranged from 0.68 to 3.83 across the studies (median rate ratio 1.11, interquartile (IQR) 0.93 to 1.37; 15 studies, 3348
participants; low-certainty evidence). It is uncertain if service utilisation (costs) are reduced in the patient-initiated compared to the
consultant-led appointment groups (8 studies, 2235 participants; very low-certainty evidence). The results suggest that adverse events
such as relapses in some conditions (inflammatory bowel disease and cancer) may have little or no reduction in the patient-initiated
appointment group in comparison with the consultant-led appointment group (MD –0.20, 95% CI –0.54 to 0.14; 3 studies, 888 participants;
low-certainty evidence). The results are unclear about any diHerences the intervention may make to patient satisfaction (SMD 0.05, 95%
CI –0.41 to 0.52; 2 studies, 375 participants) because the certainty of the evidence is low, as each study used diHerent questions to collect
their data at diHerent time points and across diHerent health conditions. Some areas of risk of bias across all the included studies was
consistently high (i.e. for blinding of participants and personnel and blinding of outcome assessment, other areas were largely of low risk
of bias or were aHected by poor reporting making the assessment unclear).
Authors' conclusions
Patient-initiated appointment systems may have little or no eHect on patient anxiety, depression and quality of life compared to consultant-
led appointment systems. Other aspects of disease status and experience also appear to show little or no diHerence between patient-
initiated and consultant-led appointment systems. Patient-initiated appointment systems may have little or no eHect on service utilisation
in terms of service contact and there is uncertainty about costs compared to consultant-led appointment systems. Patient-initiated
appointment systems may have little or no eHect on adverse events such as relapse or patient satisfaction compared to consultant-led
appointment systems.
P L A I N   L A N G U A G E   S U M M A R Y
Patient-initiated appointments for people with chronic conditions managed in hospital outpatient settings
What is the aim of this review?
We aimed to establish if patient-initiated appointments (appointments requested by the patient) for people with chronic and recurrent
conditions is a better way of managing care in hospital outpatient settings than standard appointments scheduled by the consultant.
Researchers found 17 studies to analyse.
Key messages
Overall, this review provides mainly low-quality evidence that patient-initiated appointment systems may have little or no impact on
patient anxiety, depression, quality of life, adverse events and satisfaction. This system may also have little or no impact on the contact that
patients have with services but impact on the costs of the service are unclear. There is some variability in the way patients experience care.
What is studied in the review?
Follow-up appointments scheduled by a hospital consultant is currently used for people with chronic conditions such as (but not limited
to) rheumatoid arthritis, inflammatory bowel disease and cancer. This system oOen results in missed appointments, patients unable to
access care when they need it, and a backlog of patients waiting to be diagnosed or treated for the first time. Allowing patients to access
healthcare advice and appointments when they need it (patient-initiated appointments) could help alleviate these problems and free-up
appointments. The patient-initiated system of care may also lead to greater satisfaction for patients with a more convenient service, and
may reduce costs for patients and service providers. This review compares patient-initiated appointment systems that allow the patient to
telephone a specialist nurse on a helpline, where they can discuss their query first, and have an appointment with the consultant booked as
necessary, to consultant-led appointment systems. We want to know if these systems are safe for patients to use, if patients and clinicians
find them appropriate and satisfactory to use, how they may impact patients physical and mental health, and how they may impact on
health service resources and costs.
What are the main results of the review?
Patient-initiated appointment systems for adults with chronic conditions in secondary care (Review)
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The review identified 17 studies. The studies covered six health conditions cancer (seven studies), rheumatoid arthritis (four), digestive
conditions (three), asthma (one), psoriasis (one) and coronary obstructive pulmonary disease (one). Most studies were based in the UK
(nine) but Sweden (three), Denmark (three), Finland (one) and the Netherlands (one) were also represented. The mean age of the 3854
patients ranged from 41 to 76 years and most were female. The results suggest patient-initiated appointment systems may make little or
no diHerence to patient anxiety, depression and quality of life compared to the consultant-led appointment system (low-quality evidence
due to high risk of bias and variation in results). Other aspects of disease status and experience also appear to show little or no diHerence
between patient-initiated and consultant-led appointment systems. Results for service utilisation (contact with health services and staH)
suggest there may be little or no diHerence in service contacts between the patient-initiated and consultant-led services (low-quality
evidence due to diHerent levels of contact reported across studies making it diHicult to assess). We do not know if service utilisation (costs
of services or staH) are reduced in the patient-initiated compared to the consultant-led appointment groups as the quality of this evidence
is very low (due to the risk of bias and the variability of currencies and levels of costs reported across studies). The results suggest that there
may be little or no impact on adverse events such as relapses in some conditions (cancer or inflammatory bowel disease) in the patient-
initiated appointment group in comparison with the consultant-led appointment group (low-quality evidence due to the inconsistency and
precision across studies in reporting and measuring relapse). The results suggest there may be little or no impact on patient satisfaction
(low-quality evidence as each study used diHerent questions to collect their data at diHerent time points and across diHerent illnesses). Not
all studies reported their funding sources, but of those that were reported, most were funded by not-for-profit organisations. One study
(on asthma) was funded by a pharmaceutical company.
How up-to-date is this review?
The review authors searched for studies that had been published up to March 2019.
Patient-initiated appointment systems for adults with chronic conditions in secondary care (Review)
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S U M M A R Y   O F   F I N D I N G S
 
Summary of findings for the main comparison.   Patient-initiated appointment systems compared with consultant-
led appointment systems for people with chronic conditions
Patient-initiated appointment systems compared with consultant-led appointment systems for people with chronic condi-
tions
Patient or population: adults with a chronic or recurrent condition
Settings: secondary care
Intervention: patient-initiated appointment systems






















7 studies reported anxiety, 2 could not be included in the analysis
due to data available, but findings appeared consistent. Heterogene-













7 studies reported depression, 1 could not be included in the analysis
due to data available, but findings appeared consistent. Heterogene-















12 studies reported quality of life, 5 could not be included due to da-
ta available, but where some data were available findings appeared
consistent. Heterogeneity in health condition (asthma, IBD, psoria-















Studies included different elements of service contact in their data,

















Studies included different elements of service costs in their data, da-
ta were presented in different currencies and it may be expected that
service costs vary across health condition.
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5 studies reported adverse events as relapse or recurrence, 2 could
not be included in the analysis due to data available but findings ap-
peared consistent. Each study used different questions/definitions
to collect their data at difference time points and across different










12 studies reported patient satisfaction, 10 could not be included in
the analysis due to data available but findings appeared broadly con-
sistent. Each study used different questions to collect their data at
different time points and across different health conditions. No stud-
ies reported on clinician satisfaction.
CI: confidence interval; HADS: Hospital Anxiety and Depression Scale; IBD: inflammatory bowel disease; IQR: interquartile range;
MD: mean difference; OR: odds ratio; RA: rheumatoid arthritis; SMD: standardised mean difference.
GRADE Working Group grades of evidence
High-certainty: further research is very unlikely to change our confidence in the estimate of effect.
Moderate-certainty: further research is likely to have an important impact on our confidence in the estimate of effect and may
change the estimate.
Low-certainty: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to
change the estimate.
Very low-certainty: we are very uncertain about the estimate.
aAnxiety and depression (HADS) was pooled as dichotomous data using the score of 10 as the cut point as identified in two of the papers,
continuous data were converted to dichotomous data as no other data could be retrieved from the papers presenting dichotomous data
for these outcomes.
bDowngraded two levels due serious risk of bias (lack of blinding, incomplete and selective reporting) and serious imprecision (wide
confidence intervals).
cDowngraded two levels due to serious risk of bias (lack of blinding) and serious indirectness (diHerent levels of contact reported across
studies); consistency and precision diHicult to assess.
dDowngraded three levels due to serious risk of bias (due to incomplete data), serious indirectness (as diHerent currencies and levels of
costs reported across studies) and serious imprecision.
eDowngraded two levels due to serious risk of bias (lack of blinding, selective reporting) and serious imprecision (wide confidence
intervals).
fDowngraded two levels due to serious risk of bias (lack of blinding) and serious indirectness as satisfaction was measured and reported
diHerently across studies; consistency and precision diHicult to assess.
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B A C K G R O U N D
Chronic disease has a wide impact worldwide. The World Health
Organization (WHO) reported that 63% of all deaths are from
chronic disease (WHO 2011).
Missed hospital appointments are commonly reported in
healthcare services around the world; for example, they cost
the National Health Service (NHS) in the UK millions of pounds
every year (HES 2010) (estimated GBP 225 million in 2012/2013;
National Audit OHice 2014). This unnecessary cost and a change
in public expectations has brought into question the eHiciencies
of outpatient appointment scheduling systems, particularly in
chronic conditions. Alternative appointment systems have been
explored, for example, the Expert Patient Programme (in the
UK) was specifically aimed at people with long-term conditions
(DoH 2001), early discharge with rapid access to care for patients
with chronic obstructive pulmonary disease (COPD) in Ireland
(Lawlor 2009), self-management training for people with COPD
in Canada (Bourbeau 2003), specialist nurse provision for people
with inflammatory bowel disease (IBD) in Belgium (Coenen
2017). Alternative forms of appointment scheduling may not be
appropriate for all healthcare areas, but those managing people
who have long-term or chronic conditions may see some benefits.
In 2002, the WHO published a report highlighting the need for
a model of care that more readily meets the needs of people
with chronic conditions (WHO 2002). The authors suggested that
innovations that build on evidence-based decision-making, have
a population and quality focus, and are flexible to the needs and
demands of the patient population should do well in improving the
management of chronic conditions.
More recently, both the NHS Long Term Plan (NHS 2019) and a
report on outpatient care by the Royal College of Physicians (RCP
2018) have concluded that current, more traditional models of
outpatient care are unstainable as outpatient appointments have
doubled in the last 10 years. The reports highlight how outpatient
care needs to be updated to be more flexible and cost eHective to
meet the needs of both patients and the NHS.
Description of the condition
Chronic conditions, defined as "diseases of long duration and
generally slow progression" (WHO 2013), include rheumatoid
arthritis, asthma, cancer and diabetes. People are faced with an
opportunity to manage their condition but not cure it. Traditionally,
people with these conditions are managed by the clinician through
regularly scheduled appointments (e.g. one to four times per
year) at outpatient clinics (Kirwan 1991; Probert 1993). These
appointments oOen occur at a time when a person is feeling
relatively well, with little action taken as a result. Conversely, when
symptoms recur or suddenly worsen, it may be diHicult to obtain
immediate urgent appointments. Subsequently, people are oOen
unable to get help during periods of exacerbated disease due to
the number of regular follow-up appointments also scheduled in
the system. In some cases, conditions are managed in primary care
and several studies reported the success of similar systems in this
setting (Liu 2010; Robinson 2010; Rose 2011).
Description of the intervention
A patient-initiated appointment system (PIAS) enables patients to
make appointments at times when they feel they cannot manage
their condition or where something has unexpectedly changed.
The system does not completely replace the need for a scheduled
follow-up appointment, but the new system could reduce the
number of follow-up appointments, for example, to every one to
two years.
How the intervention might work
The PIAS could free up clinician time, therefore making the service
more flexible for urgent appointments, while still being able to
deliver an acceptable standard of care. Using this type of service
may also mean that the numbers of missed appointments are
reduced (and therefore financial and resource costs are reduced
too) as most patients will be attending because they need or
choose to, and not just because the appointment is thought to
be a requirement. There is a potential risk in situations where
the patient fails to request an appointment at the time of relapse
or escalation of their condition, and symptoms become worse,
possibly critically. This risk is more likely when the appointment
systems do not include a 'safety net' appointment system (an
appointment which is scheduled by the clinician/researcher for a
certain time to ensure the patient is using the system correctly) or
when clinicians are unable to select appropriate patients for the
PIAS pathway. In addition, there are elements of preventive health
care or patient education that occur during a routine appointment
that are not addressed during a patient-initiated appointment. This
risk can be minimised by incorporating an appropriate checklist
into a 'safety net' appointment. Several studies have explored the
eHectiveness of PIAS in primary care (Liu 2010; Robinson 2010; Rose
2011). The results of some of these studies suggest that patient
initiation of care results in improvements in satisfaction with a
reduced cost for care delivery (Berkhof 2014; Robinson 2001).
Why it is important to do this review
There are several Cochrane Reviews that have considered
alternative methods to improve attendance to appointments (Car
2012; Reda 2012); however, none of these reviews has looked
at the impact of PIAS in secondary care. With the increasing
focus on healthcare eHiciencies and the increasing emphasis on
enabling people to manage their own conditions (NHS 2019;
NuHield 2011; WHO 2002), determining the benefits and harms of
PIAS in secondary care is crucial to understanding their worth for
both healthcare systems and patients.
O B J E C T I V E S
To assess the eHects of patient-initiated appointment systems
compared with consultant-led appointment systems in people with
chronic or recurrent conditions managed in secondary care.
M E T H O D S
Criteria for considering studies for this review
Types of studies
This review included randomised trials, including cluster-
randomised trials (published and unpublished and in any
language) that compared PIAS with consultant-led appointment
systems. We did not include a broader range of study designs,
as randomised trial designs are able to inform on causal
relationships more reliably than non-randomised designs; this may
be particularly important with this topic with the progressive and
Patient-initiated appointment systems for adults with chronic conditions in secondary care (Review)
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fluctuating nature of long-term conditions. Furthermore, we were
confident there was suHicient randomised trial evidence on this
topic to make evidence-based recommendations.
Types of participants
We included adults (18 years of age or older) diagnosed with any
chronic or recurrent condition, which was managed in secondary
care (we did not search for named conditions, the conditions
included in this review are those we found evidence for).
Types of interventions
A PIAS, established in the secondary care system, where
appointments can be initiated by the patient whenever they require
support from a relevant health professional to manage their
ongoing condition. The appointments must not have been used for
the purposes of diagnosis.
The comparator was a consultant-led appointment system where
patients were given a scheduled appointment to see the relevant
health professional (usually a consultant) in secondary care,
whether or not they required support. Other appointments were only
made in case of an emergency or crisis.
The intervention described here correlates with the EHective
Practice and Organisation of Care (EPOC) taxonomy of intervention
co-ordination of care and management of care processes
subcategories: care pathways; disease management and PIAS
(EPOC 2015).
Note: PIAS within a research trial may include a 'safety net'
appointment where patients do receive a scheduled appointment
with a consultant as part of the research project to make sure
participation is safe.
Types of outcome measures
We included studies that reported one or more of the following
outcomes. Studies were not excluded based on outcome.
Primary outcomes
• Patient outcomes, such as anxiety, depression, quality of life
and other health/disease status measurements (such as disease
activity, disability, self-eHicacy, pain and other disease specific
outcomes).
• Service utilisation (contacts) – contact rates with the healthcare
system including missed appointments measured through
health records.
• Service utilisation (costs).
• Adverse events.
Secondary outcomes
• Other service utilisation (other involved health service
professionals including those outside of secondary care).
• Patient satisfaction.
• Clinician (consultant or specialist nurse) satisfaction.
• Failures of the 'system' (e.g. how long people were on the
PIAS pathway but not using it correctly before the clinical team
needed to reinstigate regular follow-up clinics).
Search methods for identification of studies
Electronic searches
We searched the Cochrane Database of Systematic Reviews (CDSR)
and the Database of Abstracts of Reviews of EHects (DARE)
for primary studies included in related systematic reviews. We
searched the following databases on 13 March 2019:
• Cochrane Central Register of Controlled Trials (CENTRAL) via
Cochrane Library (2019, Issue 3);
• MEDLINE via OvidSP (1946 to 12 March 2019);
• Embase via OvidSP (1974 to 12 March 2019);
• PsycINFO via OvidSP (1806 to 12 March 2019);
• Health Technology Assessment (HTA) via CRD database (13
March 2019);
• NHS Economic Evaluation Database (NHS EED) via CRD database
(13 March 2019);
• CINAHL via EBSCOhost (1937 to 13 March 2019);
• Health Management Information Consortium (HMIC) via OvidSP
(1979 to 13 March 2019);
• ProQuest Dissertations & Theses Global via ProQuest (2015 to 13
March 2019).
Search strategies were comprised of keywords and controlled
vocabulary terms. We applied no language or time limits. Search
strategies for all databases can be found in Appendix 1.
Searching other resources
We searched for current/ongoing research on the following trial
registries:
• WHO International Clinical Trials Registry Platform (ICTRP;
www.who.int/ictrp/en/; searched 15 March 2019);
• ClinicalTrials.gov, US National Institutes of Health (NIH;
clinicaltrials.gov/; searched 15 March 2019).
We also:
• searched PROSPERO for registered systematic reviews
(www.crd.york.ac.uk/prospero/; searched 15 March 2019);
• reviewed reference lists of all included studies, relevant
systematic reviews/primary studies;
• contacted authors of relevant studies/reviews to clarify reported
published information and to seek unpublished results/data;
• contacted researchers with expertise relevant to the review
topic/ EPOC interventions;
• conducted a cited reference search for all included studies in
Scopus (4 April 2019).
Data collection and analysis
Selection of studies
Two review authors (pairs of RW, JT-C, RA, MR, VG, LA,
SB) independently screened all references at the title and
abstract stage using prespecified inclusion criteria. We resolved
disagreements though discussion. At the full-text stage, two review
authors (pairs of RW, MR, VG, LA, SB) independently screened all
references; we discussed disagreements and resolved them with a
Patient-initiated appointment systems for adults with chronic conditions in secondary care (Review)
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third review author (JT-C, RA, MP, or KS). We recorded reasons for
exclusion at the full-text stage and recorded the selection process in
suHicient detail to complete a PRISMA flow diagram (Liberati 2009).
Data extraction and management
Two review authors (pairs of RW, RA, MR, VG, LA, SB) independently
completed data extraction for all included studies. The data
extraction covered details, such as information on the participants,
setting, interventions and comparisons, outcomes and study
design, and we piloted this before use (Appendix 2; EPOC 2017a).
We discussed and resolved discrepancies with a third review author
(JTC, MP, or KS) where necessary. We contacted authors of included
papers to request clarifications and provide additional data, and
where possible, entered the data into Review Manager 5 (Review
Manager 2014).
Assessment of risk of bias in included studies
Two review authors (pairs of RW, RA, MR, VG, LA, SB) independently
assessed the risk of bias using the Cochrane 'Risk of bias' tool
(Higgins 2011). Items in this tool include sequence generation,
allocation concealment, blinding of participants and personnel,
blinding of outcome assessment, incomplete outcome data,
selective outcome reporting and other bias (such as bias in study
samples prerandomisation that are unaccounted for in analysis
or inappropriate administration of the intervention itself). We
assessed studies on the basis of having low, unclear or high risk of
bias. We discussed and resolved discrepancies with a third review
author (JTC, MP or KS) where necessary. We used the 'Risk of bias'
tool to inform the analysis and interpretation of the results, but not
as criteria for excluding studies from the review.
Measures of treatment e;ect
We expected a wide range of data (measures of treatment eHect).
We used mean diHerence (MD) when studies used the same scales
or standardised mean diHerence (SMD) when studies used diHerent
scale with 95% confidence intervals (CIs) to quantify the diHerence
between trial arms for continuous outcomes. We reported odds
ratios (OR) with 95% CIs on two analyses where we combined
continuous and dichotomous data (anxiety and depression) by
calculating the ORs and inputting them into Review Manager 5
to pool the data (Review Manager 2014). Anxiety and depression
(using the Hospital Anxiety and Depression Scale (HADS)) were
pooled as dichotomous data using the score of 10 as the cut point
as identified in two of the papers, continuous data were converted
to dichotomous data as no other data could be retrieved from the
papers presenting dichotomous data for these outcomes. There
were three analyses (rheumatoid arthritis: disability, self-eHicacy
and pain) where we used a fixed-eHect model, as the population
and measures for those outcomes were comparable. We also used
Review Manager 5 to calculate the median eHect, interquartile
range (IQR) and SMD for continuous data. We had planned to
present the risk ratios (RR) of any dichotomous data, but were
unable to do so due to the data available being mixed dichotomous
and continuous data in any one analysis.
Unit of analysis issues
Where studies had several points of follow-up, we selected the most
common point of follow-up across studies (or the point of follow-
up closest to the common point of follow-up) for each outcome
reported in a meta-analysis, otherwise we reported the longest
point of follow-up. Where studies used a cluster-randomised trial
design, but did not allow for clustering in the analysis, we adjusted
the standard error (SE) of estimate appropriately based on the
mean cluster size (i.e. number of participants per cluster) and
assumed plausible value of the intracluster correlation coeHicient
(ICC) (e.g. if the cluster was the hospital, then we assumed values
for the ICC between 0 and 0.3 for patient outcomes).
Dealing with missing data
We contacted authors for clarification and to retrieve more
information and data that we could more readily combine.
Assessment of heterogeneity
We quantified heterogeneity across estimates using the I2
statistic. We expected that the type of condition would add to the
heterogeneity of the results as well as the content/structure of the
PIAS.
Assessment of reporting biases
We did not examine the likelihood of publication bias due to
the low number of studies included in the meta-analyses. Had it
been appropriate, we would have used Egger's regression test for
asymmetry (metabias command in Stata) and funnel plots.
Data synthesis
Our analyses combined estimates of the eHect of PIAS on the
outcomes across studies. We used random-eHects meta-analyses
to pool the estimates using the DerSimonian-Laird method
(DerSimonian 1986). We performed the meta-analysis using Review
Manager 5 (Review Manager 2014). Where studies used diHerent
continuous measures to quantify a given outcome (e.g. quality
of life – 36-item Short Form (SF-36), 12-item Short Form (SF-12),
Inflammatory Bowel Disease Questionnaire (IBDQ), St George's
Respiratory Questionnaire (SGRQ), etc.), we pooled the SMD. Where
meta-analysis was not possible, we presented the data in tables
to best describe and summarise them. In particular, we could not
pool the data on service utilisation due to the varying descriptions
of the services used and variation in currency. Instead, the service
utilisation tables aim to provide a summary of the results while
taking a detailed account of the limitations and descriptions of the
data. We calculated the person-years by multiplying the number
of people in the control/intervention arm by the number of years
at follow-up. We calculated the rate ratio (as in Analysis 1.9) by
dividing the sum of the (intervention person-years divided by the
intervention total contacts) by the sum of the (control person-years
divided by the control total contacts) = rate ratio (e.g. Brown 2002;
(28/6 = 4.67)/(26/4 = 6.5) = 0.72). We also calculated the median
of the contact rate ratio to summarise the intervention eHects on
service utilisation in terms of contact with professionals, but this
was not appropriate for the analysis of costs, due to the varying
currencies used.
Summary of findings
We created a 'Summary of findings' table for the comparison,
PIAS versus consultant-led appointments, and included the most
important outcomes in order to draw conclusions about the
certainty of the evidence within the text of the review. We included
the primary outcomes of anxiety, depression, quality of life, service
utilisation (contacts and costs), and adverse events (relapse) and
the secondary outcome of patient satisfaction, as these are all
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important for decision-making (clinician satisfaction is reported as
a comment).
Two review authors (RW, RA) independently assessed the certainty
of the evidence (high, moderate, low, and very low) using the
five GRADE considerations (risk of bias, consistency of eHect,
imprecision, indirectness and publication bias) (Guyatt 2008). We
used GRADEpro to develop the GRADE table (GRADEpro GDT), and
resolved disagreements on certainty ratings by discussion and
provided justification for decisions to downgrade or upgrade the
ratings using footnotes in the table to aid readers' understanding
of the review. We used plain language statements to report these
findings in the review (EPOC 2017b).
Where it was not possible to meta-analyse the data, we summarised
the results in the text.
Subgroup analysis and investigation of heterogeneity
We conducted analyses to investigate whether pooled estimates
diHered across subgroups such as health condition. We conducted
a subgroup analysis by health condition for the outcomes that
had three or more studies with useable data (anxiety, depression
and quality of life). No other outcomes were eligible for subgroup
analysis. We were unable to conduct a subgroup analysis based on
age.
Sensitivity analysis
Sensitivity analysis would have been conducted in the case of
missing data particularly in regards to where length of follow-
up, attrition rates and units of analysis were missing or unclear.
Sensitivity analyses were conducted to check the robustness of the
results to potential risk of bias. Studies judged to be of high risk of
bias for sequence generation or allocation concealment (or both)
were excluded in secondary analyses.
R E S U L T S
Description of studies
For a full description of included studies, see Characteristics of
included studies table, and for excluded studies, see Characteristics
of excluded studies table.
Results of the search
Figure 1 presents the search of included studies from the literature
searches. We screened 18,917 titles and abstracts for inclusion,
of these, we retrieved 50 full-text articles and finally included 26
references in the review (Figure 1). The 26 references referred to 17
studies with multiple references to four studies, reflecting diHering
periods of follow-up and cost-eHectiveness analyses.
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We included 17 randomised trials (seven single site and 10 multisite
including one cluster randomised) in the review. Nine studies were
set in the UK, three in Sweden, three in Denmark, one in Finland
and one in the Netherlands.
Population
The populations represented in these studies had a mean age
ranging from 41 to 76 years. The studies covered six broad health
conditions: cancer (breast: Brown 2002; Gulliford 1997; Kirshbaum
2017; Koinberg 2004; Sheppard 2009; prostate: Helgesen 2000;
endometrial: Jeppesen 2018); rheumatoid arthritis (Fredriksson
2016; Goodwin 2016; Hewlett 2000; Primdahl 2012); digestive
conditions (IBD: Kennedy 2003; Williams 2000; ulcerative colitis:
Robinson 2001); asthma (Lahdensuo 1996); psoriasis (Khoury
2018); and coronary obstructive pulmonary disease (Berkhof 2014).
The cancer studies had either men or women in their populations
but the other health conditions used mixed populations, although
women dominated in almost every mixed study (nine reported 52%
to 77% with one study at 26% and one at 36%), which may reflect an
increased incidence of these conditions within women. The sample
sizes ranged from 61 to 635 participants (total 3854), and length of
follow-up ranged from 10 to 72 months.
Interventions
The interventions all involved patients (or the patients' GP) being
able to access disease-specific advice and care by telephoning
their hospital. In most interventions, the patient contacted a
specialist nurse who was able to give immediate advice, ask a
doctor for further advice to give to the patient and arrange an
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outpatient appointment if necessary. When enrolling into the
intervention, some patients were given personal education by
trained nurses (Kirshbaum 2017; Lahdensuo 1996), or doctors
(Jeppesen 2018); some were given general written information/
guidance (Brown 2002; Hewlett 2000; Kirshbaum 2017); and some
received a personalised guided self-management plan (Kennedy
2003; Robinson 2001). The remaining studies did not report this
level of detail, though some written materials may be assumed in
the process of enrolling within the healthcare context. Most studies
ran a safety net procedure for the duration of the study in the
form of an annual hospital review (Berkhof 2014; Goodwin 2016;
Khoury 2018; Primdahl 2012); an annual mammogram (Brown
2002; Gulliford 1997; Koinberg 2004; Sheppard 2009); or another
review or contact at three months (Hewlett 2000; Fredriksson 2016),
four months (Lahdensuo 1996), six months (Helgesen 2000), or
24 months (Williams 2000). Only four studies reported no safety
net procedures (Jeppesen 2018; Kennedy 2003; Kirshbaum 2017;
Robinson 2001).
Comparisons
The comparator for each study was a consultant-led clinic
appointment with varying appointment schedules across the
studies. Some studies reported that those in the comparator
condition could receive an emergency appointment if necessary
(Fredriksson 2016; Gulliford 1997; Helgesen 2000; Hewlett 2000;
Khoury 2018; Primdahl 2012; Williams 2000), but for the remainder
the availability of this service was unclear. For full details, see the
Characteristics of included studies tables.
Outcomes
The review included the following outcomes (studies were not
excluded based on outcome).
Primary outcomes
Sixteen studies reported on patient outcomes, such as anxiety
(Brown 2002; Helgesen 2000; Hewlett 2000; Kennedy 2003; Khoury
2018; Kirshbaum 2017; Koinberg 2004); depression (Brown 2002;
Helgesen 2000; Hewlett 2000; Kennedy 2003; Khoury 2018;
Kirshbaum 2017; Koinberg 2004); quality of life (Berkhof 2014;
Brown 2002; Gulliford 1997; Hewlett 2000; Kennedy 2003; Khoury
2018; Kirshbaum 2017; Lahdensuo 1996; Primdahl 2012; Robinson
2001; Sheppard 2009; Williams 2000); and other health/disease
status measurements such as disease activity (Hewlett 2000;
Primdahl 2012), disability (Hewlett 2000; Primdahl 2012), self-
eHicacy (Hewlett 2000; Primdahl 2012), pain (Hewlett 2000;
Primdahl 2012), and other disease-specific outcomes (Berkhof
2014; Brown 2002; Fredriksson 2016; Gulliford 1997; Helgesen
2000; Hewlett 2000; Jeppesen 2018; Kennedy 2003; Khoury 2018;
Koinberg 2004; Lahdensuo 1996; Primdahl 2012; Robinson 2001;
Sheppard 2009; Williams 2000).
FiOeen studies reported on service utilisation, such as contact
rates with the healthcare system (Brown 2002; Fredriksson 2016;
Goodwin 2016; Gulliford 1997; Helgesen 2000; Hewlett 2000;
Jeppesen 2018; Kennedy 2003; Khoury 2018; Koinberg 2004;
Lahdensuo 1996; Primdahl 2012; Robinson 2001; Sheppard 2009;
Williams 2000), including missed appointments measured through
health records (Kennedy 2003; Khoury 2018), and costs (Berkhof
2014; Goodwin 2016; Helgesen 2000; Hewlett 2000; Kennedy 2003;
Koinberg 2004; Primdahl 2012; Williams 2000).
Four studies reported on adverse events (Berkhof 2014; Kennedy
2003; Robinson 2001; Sheppard 2009).
Secondary outcomes
No studies reported on other service utilisation other than that
which was captured in service utilisation contacts.
Twelve studies reported on patient satisfaction in some way (Brown
2002; Fredriksson 2016; Goodwin 2016; Gulliford 1997; Helgesen
2000; Hewlett 2000; Kennedy 2003; Khoury 2018; Koinberg 2004;
Primdahl 2012; Robinson 2001; Williams 2000).
No studies reported on clinician (consultant or specialist nurse)
satisfaction.
One study reported on failures of the 'system' such as 'safety net'
failure (Hewlett 2000).
Funding source
Of the 17 studies, two did not report their funding source (Brown
2002; Kirshbaum 2017). Of the 15 studies that did report their
funding source, 14 were funded by not-for-profit organisations
such as local government or health groups or health charity
organisations, one study was funded by an industry organisation.
Excluded studies
We excluded 23 studies at the full-text screening stage: 12 because
they were not a randomised trial, 10 were the wrong intervention
and one had the wrong population. See Characteristics of excluded
studies table for full details.
Ongoing studies
We identified one ongoing study, which commenced in 2015 and
the findings are yet to be reported. See Characteristics of ongoing
studies table for full details.
Risk of bias in included studies
See the 'Risk of bias' tables within the Characteristics of included
studies table, Figure 2 for a summary of judgements about each risk
of bias item and Figure 3 for a graph of risk of bias items presented
as percentages across all included studies.
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Figure 2.   Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
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Figure 3.   Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages




Random sequence generation was low risk in 14 studies with
methods such as computer-generated randomisation, numbers
pulled randomly from a hat or random number tables (Berkhof
2014; Brown 2002; Fredriksson 2016; Goodwin 2016; Hewlett
2000; Jeppesen 2018; Kennedy 2003; Khoury 2018; Koinberg 2004;
Lahdensuo 1996; Primdahl 2012; Robinson 2001; Sheppard 2009;
Williams 2000). There were three studies at unclear risk due to the
lack of reporting on the random sequence generation (Gulliford
1997; Helgesen 2000; Kirshbaum 2017). No studies were at high risk.
Allocation concealment
Allocation concealment was at low risk in 11 studies where
allocations were concealed in sealed envelopes or dealt with by a
third party not directly involved in the study, or both (Fredriksson
2016; Helgesen 2000; Hewlett 2000; Jeppesen 2018; Kennedy 2003;
Koinberg 2004; Lahdensuo 1996; Primdahl 2012; Robinson 2001;
Sheppard 2009; Williams 2000). There were six studies at unclear
risk due to the lack of reporting on the allocation concealment
(Berkhof 2014; Brown 2002; Goodwin 2016; Gulliford 1997; Khoury
2018; Kirshbaum 2017). No studies were at high risk.
Blinding
Blinding of participants and personnel
No studies were at low risk of blinding of participants and personnel
as, due to the nature of the intervention, participants would
know which arm of the trial they were in. There was one study
at unclear risk due to the lack of reporting on the this area of
blinding (Gulliford 1997). Sixteen studies were at high risk due to
the obvious nature of the intervention (whether they were given
allocated appointments by the consultant or were able to make
their own appointments) (Berkhof 2014; Brown 2002; Fredriksson
2016; Goodwin 2016; Helgesen 2000; Hewlett 2000; Jeppesen 2018;
Kennedy 2003; Khoury 2018; Kirshbaum 2017; Koinberg 2004;
Lahdensuo 1996; Primdahl 2012; Robinson 2001; Sheppard 2009;
Williams 2000).
Blinding of outcome assessment
No studies were at low risk of blinding of outcome assessment
as many of the outcomes were self-reported and this may have
influenced the interpretation of the results around these outcomes.
There were three studies at unclear risk due to the lack of
reporting (Fredriksson 2016; Lahdensuo 1996; Robinson 2001).
Fourteen studies were at high risk due to the obvious nature of
the intervention (whether they were given allocated appointments
by the consultant or were able to make their own appointments);
this is largely due to the self-reporting nature of the outcomes of
interest by the patients or because the blinding of other outcome
assessors was not reported or unclear (Berkhof 2014; Brown
2002; Goodwin 2016; Gulliford 1997; Helgesen 2000; Hewlett 2000;
Jeppesen 2018; Kennedy 2003; Khoury 2018; Kirshbaum 2017;
Koinberg 2004; Primdahl 2012; Sheppard 2009; Williams 2000).
Incomplete outcome data
Incomplete outcome data was at low risk for nine studies (Berkhof
2014; Fredriksson 2016; Hewlett 2000; Jeppesen 2018; Kennedy
2003; Khoury 2018; Primdahl 2012; Robinson 2001; Williams 2000).
Three studies were at unclear risk due to the poor reporting of
this outcome in those studies (Gulliford 1997; Kirshbaum 2017;
Koinberg 2004). Five studies were at high risk of incomplete
outcome data as it was sometimes unclear where the attrition lay
or why data was lost or where lost data was not accounted for
appropriately in the analysis (Brown 2002; Goodwin 2016; Helgesen
2000; Lahdensuo 1996; Sheppard 2009).
Selective reporting
Selective reporting was at low risk in 11 studies where all the
outcomes appeared to be reported for the necessary time points
(Berkhof 2014; Brown 2002; Fredriksson 2016; Goodwin 2016;
Helgesen 2000; Kennedy 2003; Kirshbaum 2017; Lahdensuo 1996;
Primdahl 2012; Sheppard 2009; Williams 2000). Six studies were
at high risk, one as it did not report the results of all participants
but only those who completed all the assessments and there are
no details about those who did not complete all the assessments
or why (Hewlett 2000), and five that did not fully report all the
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outcomes they specified (Gulliford 1997; Jeppesen 2018; Khoury
2018; Koinberg 2004; Robinson 2001).
Other potential sources of bias
In other potential sources of bias, we looked at anything else that
could have aHected the study results that could not be accounted
for above such as problems with study samples prerandomisation
or problems with inappropriate administration of the intervention
itself. In this area, 11 studies were at low risk where there was no
evidence of further bias (Berkhof 2014; Fredriksson 2016; Goodwin
2016; Gulliford 1997; Helgesen 2000; Hewlett 2000; Kennedy 2003;
Khoury 2018; Lahdensuo 1996; Primdahl 2012; Robinson 2001).
Two studies were at unclear risk where there was a diHerence in
the administration of the intervention but the impact on the results
was diHicult to establish (Kirshbaum 2017; Williams 2000). Four
studies were at high risk of other bias due to these studies having
unaccounted for instances of participants declining to participate
in part due to not wanting to be randomised – this could be showing
some type of characteristic diHerence in the participants which the
study was unable to explore or account for (Brown 2002; Jeppesen
2018; Koinberg 2004; Sheppard 2009). One study also reported
diHiculties with administering the intervention itself but this was
not further described (Koinberg 2004).
E;ects of interventions
See: Summary of findings for the main comparison Patient-
initiated appointment systems compared with consultant-led
appointment systems for people with chronic conditions
We were able to perform meta-analyses across health conditions on
three outcomes (anxiety, depression and quality of life). We were
also able to perform a series of small meta-analyses within the
studies on rheumatoid arthritis for five outcomes (disease activity,
disability, self-eHicacy, pain and patient satisfaction) and within
IBD for the outcome of relapses only. The remaining outcomes
(primary and secondary) are presented in other data comparison
tables. In general, collating of data from studies both within and
across health conditions was limited and complex in nature due to
the range of tools used to measure the same or similar concepts,
the diHering time points at which data were collected, the diHering
units data were presented in, and the diHering analyses and
data that were reported. These factors, alongside the risk of bias
identified across studies, have led us to report the certainty of the
evidence (using GRADE) in this review as ranging mainly from low
to very low, meaning we are quite uncertain about the estimate of
eHect on all the outcomes reported (Guyatt 2008).
See Summary of findings for the main comparison.
Patient-initiated appointment systems versus consultant-led
appointment systems
Primary outcomes
The studies for each of the meta-analyses were selected based
on the outcome reported, the closest common time point of data
available (usually 12 to 24 months) and the availability of the data
in the correct format.
Patient outcomes
Anxiety
Seven studies (1780 participants) reported anxiety – four were
studies that recruited people with cancer, one recruited people
with psoriasis, one recruited people with IBD and one recruited
people with rheumatoid arthritis, all used the Hospital Anxiety and
Depression Scale (HADS) as their measure. In the HADS scale, lower
scores indicate fewer symptoms of anxiety or depression (range 0
to 21). The meta-analysis was conducted using five of these studies
(1019 participants) (Helgesen 2000 at 12 months; Hewlett 2000 at 24
months; Khoury 2018 at 12 months; Kirshbaum 2017 at 12 months;
Koinberg 2004 at 18 months). The results suggest PIAS may make
little or no diHerence to patient anxiety, with all studies reporting
considerably wide CIs (OR 0.87, 95% CI 0.68 to 1.12; 5 studies, 1019
participants; I2 = 0%; low-certainty evidence; Analysis 1.1; Figure
4). The GRADE rating of the evidence for anxiety was downgraded
twice to low certainty due to serious risk of bias and imprecision.
Sensitivity analysis including only studies at low risk of bias for
random sequence generation, allocation concealment or for length
of follow-up did not change the results.
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Figure 4.   Forest plot of comparison: 1 Patient-initiated appointment systems versus consultant-led appointment
systems, outcome: 1.1 Patient outcomes: anxiety (HADS lower score = better 0–21) (12–24 months).
 
Brown 2002 and Kennedy 2003 (2 studies, 761 participants) also
reported on anxiety using the same scale; however, we were unable
to retrieve the necessary data to include them in the meta-analysis
(Kennedy 2003 could not provide separate data for the anxiety
outcome but reported no significant diHerence in the text – no
data available). Brown 2002 also reported no significant diHerence
in anxiety scores between the PIAS group and the consultant-led
group (median score: 4 with PIAS versus 6.5 with consultant-led; P
= 0.069 at 12 months).
Depression
Seven studies (1896 participants) reported on depression – four
were studies that recruited people with cancer, one recruited
people with rheumatoid arthritis, one recruited people with
psoriasis and one recruited people with IBD, with all using HADS
as their measure (0 to 21 where lower scores indicate fewer
symptoms). The meta-analysis was conducted using six of these
studies (1835 participants) (Helgesen 2000 at 12 months; Hewlett
2000 at 24 months; Kennedy 2003 at nine months; Khoury 2018
at 12 months; Kirshbaum 2017 at 12 months; Koinberg 2004 at
18 months). These results suggest PIAS may make little or no
diHerence to patient depression (OR 0.79, 95% CI 0.51 to 1.23;
6 studies, 1175 participants; I2 = 33%; low-certainty evidence;
Analysis 1.2; Figure 5). The GRADE rating of the evidence for
depression was downgraded twice to low certainty due to high risk
of bias and imprecision. Sensitivity analysis including only studies
at low risk of bias for random sequence generation, allocation
concealment or length of follow-up did not change the results.
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Figure 5.   Forest plot of comparison: 1 Patient-initiated appointment systems versus consultant-led appointment
systems, outcome: 1.2 Patient outcomes: depression (HADS lower score = better 0–21) (9–24 months).
 
Brown 2002 (61 participants) also reported on depression at 12
months using the same scale. We were unable to retrieve the
necessary data to include the study in the meta-analysis but
they reported no significant diHerence in the text between groups
(median score: 1 with PIAS versus 2 with consultant-led; P = 0.232).
Quality of life
Twelve studies (2232 participants) reported quality of life – four
recruited people with cancer, three recruited people with IBD,
one recruited people with psoriasis, two recruited people with
rheumatoid arthritis, one recruited people with COPD and one
recruited people with asthma, each using a diHerent measure
of quality of life, with the exception of two IBD studies. For
the quality of life measures, higher scores indicate better quality
of life. The meta-analysis was conducted using seven of these
studies (1486 participants) (Sheppard 2009 Functional Assessment
of Cancer Therapy (FACT-B) plus endocrine subscale at 18 months;
Lahdensuo 1996 Part 3 St George's Asthma Questionnaire at 12
months; Robinson 2001 IBDQ at 14 months; Primdahl 2012 EQ-5D
at 12 months; Kennedy 2003 IBDQ at 12 months; Khoury 2018
Dermatology Life Quality Index (DLQI) at 12 months; Kirshbaum
2017 European Organisation for Research and Treatment of Cancer
EORTC QLQ-C30 global scale at 12 months). The results suggest that
PIAS may make little or no diHerence to patient quality of life (SMD
0.12, 95% CI –0.00 to 0.25; 7 studies, 1486 participants; I2 = 29%; low-
certainty evidence; Analysis 1.3; Figure 6). The GRADE rating of the
evidence for quality of life was downgraded two levels to low due to
serious risk of bias and imprecision. Sensitivity analysis including
only studies at low risk of bias for random sequence generation,
allocation concealment or length of follow-up did not change the
results.
 
Patient-initiated appointment systems for adults with chronic conditions in secondary care (Review)









Cochrane Database of Systematic Reviews
Figure 6.   Forest plot of comparison: 1 Patient-initiated appointment systems versus consultant-led appointment
systems, outcome: 1.3 Patient outcomes: quality of life (12–18 months).
 
Five studies (746 participants) also reported quality of life using
diHering measures and diHering time points, and found similar
results in that there appears to be little evidence of diHerences
between the PIAS and consultant-led appointment groups. Brown
2002 reported no significant diHerences between the PIAS and the
consultant-led group using the EORTC QLQ-C30 global scale at 12
months (median score: 11 with PIAS versus 10 with consultant-
led; no significant diHerence). Gulliford 1997 did not report results.
Hewlett 2000 measured quality of life using the SF-36 at 36 months
but presented no data. Williams 2000 reported no significant
diHerences on the UK IBDQ or the SF-36 at 12 months (no
total scores provided but all diHerences in subscales were not
significant). Berkhof 2014 reported no significant diHerence at 24
months on the SF-36 questionnaire (mean change from baseline: –
5.2 with PIAS versus –4.8 with consultant-led; 95% CI –6.7 to 5.8; P
= 0.89).
Other health/disease status measurements
FiOeen studies reported on other health/disease status
measurements across all the health conditions; however, data from
only two studies were able to be combined in a meta-analysis.
These were in studies that recruited people with rheumatoid
arthritis (Hewlett 2000; Primdahl 2012). For two of these studies,
we ran small meta-analyses on outcomes such as disease activity
(Analysis 1.4), self-eHicacy (Analysis 1.5), pain (Analysis 1.6) and
disability (Analysis 1.7) related to this particular condition. The
studies measured disease activity using a visual analogue scale
(VAS; 1 mm to 100 mm) and the Disease Activity Scale (DAS)
where lower scores are better (a score of 5.1 or more implies
active disease, less than 3.2 low disease activity, and less than
2.6 remission; at 24 months). Disease activity is probably slightly
reduced in the PIAS group compared with the consultant-led group
(SMD –0.21, 95% CI –0.41 to –0.01; 2 studies, 375 participants; I2
= 0%; moderate-certainty evidence), but this was unlikely to be
clinically significant where for the DAS a persistent reduction in
score of 1.2 from the original score is required to allow continuation
of treatment (NRAS 2020). Fredriksson 2016 also used DAS to
measure disease activity and found no significant diHerences
between the PIAS group and the consultant-led group at 18 months
(mean change from baseline: 0.24 with PIAS versus 0.59 with
consultant-led, 95% CI –0.01 to 0.91; P = 0.055).
The results regarding self-eHicacy measured using the Arthritis Self-
EHicacy Scales (ASES; higher scores are better – range 0 to 100)
suggest self-eHicacy is probably slightly increased in PIAS group
compared with the consultant-led group at 24 months (MD 4.95,
95% CI 0.57 to 9.34; 2 studies, 375 participants; I2 = 20%; moderate-
certainty evidence), but that the diHerence may not be clinically
significant (minimal clinically important diHerence 8.5 on ASES;
Park 2019).
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The results regarding pain (measured using VAS at 12 months where
lower scores are better 1 cm to 10 cm), suggest PIAS probably
slightly reduces pain in comparison to consultant-led appointment
groups (MD –0.71, 95% CI –1.17 to –0.26; 2 studies, 375 participants;
I2 = 46%; moderate-certainty evidence), but that the diHerence may
not be clinically significant (minimal clinically important diHerence
–1.19 cm Kitchen 2013). Fredriksson 2016 also measured pain using
VAS and found no diHerences (median change from baseline: –3
(IQR –13 to 5) with PIAS versus –4 (IQR –18 to 8) with consultant-led;
1 study, 131 participants; P = 0.75).
The results regarding disability (measured using Health
Assessment Questionnaire (HAQ); score range 0 to 3) where lower
scores are better) suggest there is probably little or no diHerence
between PIAS and consultant-led appointment groups on disability
scores at 12 months (MD –0.06, 95% CI –0.19 to 0.06; 2 studies, 375
participants; I2 = 0%; moderate-certainty evidence). The minimal
clinically important diHerence on the HAQ is 0.22 (Kitchen 2013).
Fredriksson 2016 also measured disability using the HAQ and found
no significant diHerences between the PIAS and the consultant-led
group in the MD since baseline at 18 months (median change from
baseline: –0.12 (IQR –0.25 to 0.13) with PIAS versus –0.11 (IQR –0.25
to 0.12) with consultant-led; P = 0.91). The GRADE of evidence for
these studies was downgraded once to moderate due to serious risk
of bias in these studies.
The remaining measures of disease-specific and other outcomes
of interest reported by individual studies can be found in Analysis
1.14; Analysis 1.15; Analysis 1.16; Analysis 1.17; Analysis 1.18; and
Analysis 1.19). A brief summary of these outcomes follows.
Berkhof 2014 described three additional COPD and respiratory
symptom outcomes which reported no diHerences from baseline to
24-month follow-up for the PIAS or the consultant-led groups, and
no diHerence in the time it took to experience an exacerbation of the
condition between the PIAS and consultant-led groups (Analysis
1.14; P = 0.40).
Seven additional outcomes were reported for cancer (Analysis
1.15). Gulliford 1997 reported that the proportion of participants
reassured with the service at 16 months was slightly higher for the
consultant-led group (94%) than the PIAS group (88%); Helgesen
2000 found that the proportion of participants reporting the service
inaccessible by telephone at 36 months was slightly higher for
the PIAS group than the consultant-led group (RR 1.18, 95% CI
0.46 to 3.03); Jeppesen 2018 reported fear of cancer recurrence
at 10 months was slightly higher in the PIAS group in comparison
to the consultant-led group (P = 0.02), but also that clinical fear
of recurrence at 10 months showed no diHerence between the
groups (P = 0.89); Koinberg 2004 reported on the accessibility of
the service by telephone at 60 months but suggested contrasting
evidence to that of Helgesen 2000 by finding little or no diHerence
between the groups; Sheppard 2009 reported no substantial
diHerences between the PIAS and the consultant-led groups on fear
of recurrence at 18 months (P = 0.066) or the proportion of people
feeling isolated (P = 0.245).
Five studies reported additional outcomes for IBD (Analysis 1.16):
Kennedy 2003 found participants in the PIAS group compared to
the consultant-led group were more likely to feel enabled aOer their
initial consultation (MD 0.026, 95% CI 0.12 to 1.68) and more likely to
make appointments for themselves (MD 2.70, 95% CI 1.63 to 4.46; P
< 0.001), with little diHerence in the delay before starting treatment
between the two groups (MD 0.95, 95% CI –0.52 to 0.49). Conversely,
Robinson 2001 reported that the time to symptom treatment was
substantially longer for the consultant-led group (mean 49.6 hours)
in comparison to the PIAS group (mean 14.8 hours; P < 0.0001),
they also reported that the cost to the patient at 14 months was
considerably less in the PIAS group (mean GBP 0.86) compared to
the consultant-led group (mean GBP 8.92; P < 0.0001).
Khoury 2018 reported on four additional outcomes for psoriasis
(Analysis 1.17). At 12 months, there was little diHerence between
PIAS and consultant-led groups in missed laboratory tests (MD –
0.10, 95% CI –0.20 to 0.18) and disease activity (MD –0.24, 95%
CI –0.84 to 0.36). Whereas missed medication collection at 12
months happened more frequently in the PIAS group compared to
the consultant-led group (MD –0.10, 95% CI –0.024 to –0.04) and
changes in medication at 12 months happened more frequently in
the consultant-led group (20.6%) in comparison to the PIAS group
(6.8%; P < 0.001).
Two studies reported 10 additional outcomes for rheumatoid
arthritis (Analysis 1.18). There was no substantial diHerence for
confidence in care, general health, number of swollen joints,
number of tender joints and C-reactive protein levels between
baseline and follow-up at 18 months for the PIAS and consultant-
led groups; however, the number of cases where treatment
was changed (P = 0.0002) and the erythrocyte sedimentation
rate diHered substantially (P = 0.03) between the two groups
(Fredriksson 2016). Hewlett 2000 reported that participants in the
PIAS group were more likely to be confident with their interventions
than those in the consultant-led group (P < 0.01), but found little
diHerence in the change from baseline in terms of feelings of
helplessness in the two groups.
For asthma, Lahdensuo 1996 reported on lung function and
found no diHerences between the PIAS and consultant-led groups
(Analysis 1.19). This study also reported a diHerence in the number
of days oH work with participants in the PIAS group taking fewer
days oH work (mean 2.8 SD 0 to 62) than those in the consultant-led
group (mean 4.8, SD 0 to 27; P = 0.02).
The data available for these outcomes were variable and
incomplete, which makes it diHicult to draw these results together
and interpret them in a way that might be useful for the reader.
Service utilisation (contacts)
Sixteen studies reported service utilisation in terms of
appointments or telephone calls (contacts) with various healthcare
professionals. The results suggest there may be little or no
diHerence in service utilisation (including hospital appointments,
referrals, telephone calls, GP visits, nurse visits, other outpatient
contacts, e.g. occupational therapist, physiotherapist, podiatrist,
orthopaedic surgeon, orthotics, and tests) in terms of contacts with
health professionals/services between the PIAS and consultant-led
appointment groups at 12 to 60 months (range 0.68 to 3.83 across
the studies; median rate ratio 1.11, IQR 0.93 to 1.37; 15 studies, 3348
participants; low-certainty evidence). Each study included diHerent
elements of service contact in their data, and there may be some
expectation that contact might vary between health conditions (see
Analysis 1.9 for details). We downgraded the evidence twice to
low certainty due to serious risk of bias and imprecision in these
studies. The rate ratio does not account for clusters of events/
contacts within the same person. Berkhof 2014 (100 participants)
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could not be included in Analysis 1.9 as we were unable to obtain
the appropriate data but their results suggest the GP was visited
less frequently in the PIAS compared to the consultant-led group
(median number of visits: 4 (range 0 to 32) with PIAS versus 5 ( range
0 to 20) with consultant-led; P = 0.01); the pulmonologist was visited
similarly in each group (median number of visits: 3 (range 0 to 17)
with PIAS versus 3 (range 0 to 13) with consultant-led; P = 0.82); and
the pulmonary nurse practitioner was visited more oOen in the PIAS
compared to the consultant-led group (median number of visits: 1
(range 0 to 14) with PIAS versus 0 (range 0 to 4) with consultant-led;
P = 0.003).
Two studies (599 participants) report on missed appointments –
one recruited people with IBD (Kennedy 2003), and one recruited
people with psoriasis (Khoury 2018). The results suggest missed
appointments may be slightly reduced in the PIAS group compared
with the consultant-led group (MD –0.27, 95% CI –0.42 to –0.12; 2
studies, 599 participants; I2 = 0%; low-certainty evidence; Analysis
1.11). The results were downgraded due to serious risk of bias and
imprecision (wide CIs).
Service utilisation (costs)
Eight studies reported service utilisation in terms of financial costs.
We do not know if service utilisation (costs) are reduced in the PIAS
compared to the consultant-led appointment groups as there is
very low-certainty evidence (8 studies, 2235 participants). Although
six of the eight studies reported reduced costs per patient-year in
the PIAS group compared with the consultant-led group, the eHect
is not certain as each study included diHerent elements of service
costs in their data, data were presented in diHerent currencies, and
there may be some expectation that service costs will vary between
health conditions and locations (see Analysis 1.10 for details).
The evidence was downgraded three times due to serious risk of
bias (due to incomplete data), serious indirectness (as diHerent
currencies and levels of costs reported across studies) and serious
imprecision.
Adverse events
Seven studies (1819 participants) reported adverse events. Five
studies (1202 participants) reported relapse or exacerbations
or recurrences of the condition (Berkhof 2014; Kennedy 2003;
Koinberg 2004; Robinson 2001; Sheppard 2009). We were able
to meta-analyse data from three studies on relapse occurrence
(Kennedy 2003; Koinberg 2004; Robinson 2001). The results suggest
that the intervention may make little or no diHerence to relapses
between the PIAS group and the consultant-led group at 12 to 60
months (MD –0.20, 95% CI –0.54 to 0.14; 3 studies, 888 participants;
I2 = 67%; low-certainty evidence; Analysis 1.12).
Two studies (314 participants) reported relapse within cancer
and COPD. Sheppard 2009 reported no significant diHerences in
the percentage of patients with cancer recurrence between the
PIAS group and the consultant-led group at 18 months (rate of
recurrence was 4% in both groups). Berkhof 2014 reported no
significant diHerence in the number of patients with at least one
exacerbation of COPD between the PIAS group and the consultant-
led group at 24 months (38.8% with PIAS versus 31.4% with
consultant-led; P = 0.44). The GRADE of evidence for these studies
was downgraded twice to low certainty due to serious risk of bias
and imprecision (wide CIs) in these studies.
Two studies (315 participants) reported other adverse events
and use of other drugs to assist the condition (Lahdensuo 1996;
Primdahl 2012). Only one study (122 participants) reported other
adverse events such as use of antibiotics and use of prednisolone
(Lahdensuo 1996). This study found that people with asthma within
the PIAS group were significantly less likely to report use of other
drugs at 12 months than those in consultant-led appointment
group (adverse events: 0.6 with PIAS versus 2.1 with consultant-led;
95% CI 0.9 to 2.1; P < 0.0001). Primdahl 2012 report no significant
diHerences in the number of adverse eHect alerts between people
with rheumatoid arthritis in the PIAS group (mean 1.19) and the
consultant-led group (mean 1.61) at 24 months.
Secondary outcomes
Other service utilisation
None of the studies reported this separately from the 'Service
utilisation (contacts)' and 'Service utilisation (costs)' recorded
above.
Patient satisfaction
Twelve studies (2950 participants) reported patient satisfaction
with (and acceptability of) the intervention (see Analysis 1.13 and
Analysis 1.8 where higher scores indicate better satisfaction). The
results were unclear about any diHerences the intervention may
make to patient satisfaction as the certainty of the evidence was
low. Of the four studies that recruited people with rheumatoid
arthritis (796 patients) (Fredriksson 2016; Goodwin 2016; Hewlett
2000; Primdahl 2012), meta analysis was conducted on two studies
(375 participants) (Hewlett 2000; Primdahl 2012) and suggest
that PIAS had little or no eHect on satisfaction compared to the
consultant-led system at 12 to 24 months (SMD 0.05, 95% CI –
0.41 to 0.52; 2 studies, 375 participants; I2 = 81%; low-certainty
evidence). A third study (131 participants) (Fredriksson 2016) could
not be included in the analysis but also reported little or no
diHerence between the groups. The fourth study (290 participants)
Goodwin 2016 also could not be included in the analysis but
reported a significant diHerence (p = 0.002) between the groups
with greater satisfaction with the service in the PIAS compared to
the consultant-led system. We downgraded the evidence twice to
low certainty due to serious risk of bias and indirectness.
The results across other conditions were also variable (see Analysis
1.13 for more details for each study). For example, of the four
studies reporting patient satisfaction in people with cancer (921
patients), one reported that the consultant-led group had greater
satisfaction than the PIAS group though significance was not
reported (mean: 122 (SE 91.6) with PIAS versus 130 (SE 98.9) with
consultant-led; 264 participants at 60 months; Koinberg 2004). Of
the three studies reporting patient satisfaction in people with IBD,
two reported that the PIAS group may have greater satisfaction
than the consultant-led group (Kennedy 2003: mean: 54.6 (SD 8.5)
with PIAS versus 53.6 (SD 9.1) with consultant-led; 95% CI –3.67 to
6.03; P = 0.62; Williams 2000: mean: 69 (SE 85) with PIAS versus
4 (SE 41) with consultant-led; P < 0.01; 280 participants at 12
to 24 months) but with varying levels of significance. One study
reporting patient satisfaction in people with psoriasis reported no
diHerence between the PIAS group and the consultant-led group
(Khoury 2018: mean: 3.6 (SE 0.1) with PIAS versus 3.5 (SE 0.1) with
consultant-led; P = 0.75; 147 participants at 12 months).
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Clinician (consultant or specialist nurse) satisfaction
None of the studies reported clinician (consultant or specialist
nurse) satisfaction.
Failures of the 'system'
None of the studies reported outcomes regarding failures of the
'system' (e.g. how long participants are on the PIAS pathway but
not using it correctly before the clinical team needs to reinstigate
regular follow-up clinics). One study (209 participants) reported
safety net failure. Hewlett 2000 defined a safety net failure as an
increase of more than 20% of the clinical experience of pain, disease
activity or disability as recorded on the relevant scales. This study
reported no significant diHerences in the number of safety net
failures between the people with rheumatoid arthritis in the PIAS
group (26.5%) and the consultant-led group (28.9%) at 24 months.
D I S C U S S I O N
Summary of main results
In this review of PIASs, we included 17 studies reported in 26
papers. The studies involved 3854 adults all enrolled in a PIAS
or in consultant-led appointment systems across six conditions:
cancer, rheumatoid arthritis, IBD, asthma, psoriasis and COPD.
Study follow-up ranged from 12 to 72 months, with the most
commonly reported time points (those used in meta-analyses)
being 12 to 24 months.
The review provides mainly low-certainty evidence for PIASs
on a number of outcomes, as well as some less-frequently
reported outcomes of interest (Summary of findings for the
main comparison). The results of meta-analyses provide some
indication of the likely eHect; however, the likelihood that it will
be substantially diHerent is high. The results suggest PIAS may
have little or no impact on patient anxiety, depression and quality
of life. For other health disease status measurements, such as
disease activity and pain, results suggest these are probably slightly
reduced in the PIAS group compared with the consultant-led group.
There is probably little or no impact on disability between PIAS
and consultant-led groups, and self-eHicacy is probably slightly
increased in the PIAS group compared with the consultant-led
group. Other aspects of disease status and experience appear
to show little or no diHerence between PIAS and consultant-led
appointment systems.
The results for service utilisation (contacts) are mixed with no clear
indication of reduced or increased service contact. Linked to this,
results also suggest missed appointments may be slightly reduced
in the PIAS group compared with the consultant-led group. We
do not know if service utilisation (costs) could be reduced in the
PIAS compared to the consultant-led appointment groups due to
the low-certainty evidence and because we did not use a currency
convertor to establish a common currency, this decision was made
in part due to the fact the studies did not report consistently on the
services they included in their costs which also made the evidence
less comparable across studies.
The results for adverse events suggest people within the PIAS group
may be no more or less likely to report a relapse or recurrence
of their condition or other adverse eHects compared with the
consultant-led group. Evidence from one study suggests people
with asthma within the PIAS group were significantly less likely to
report use of other drugs at 12 months than those in consultant-led
appointment group but this is based on low-certainty evidence.
It is also uncertain whether PIAS improve patient satisfaction
because the certainty of evidence is low, each study used diHerent
questions to collect their data at diHerent time points and across
diHerent health conditions. This may also reflect the perceived
severity of the condition or the ease with which symptoms can be
identified.
None of the studies reported failures of the system other than safety
net failure or clinician (consultant or specialist nurse) satisfaction.
Overall completeness and applicability of evidence
This review highlights a few issues concerning the completeness
and applicability of the evidence.
First, we found few published studies investigating this question
across diHering health conditions. We suspect that much of this
type of service change may occur without evaluations being
published. This may mean there is some form of publication bias to
be considered or may mean that these types of service changes are
evolving (or not) within the clinical context with only local internal
evaluations being conducted.
Second, we noticed a distinct lack of studies from outside Europe.
This might reflect the diHering healthcare system structures in
place internationally or a lack of reporting of this type of system
change. It may also reflect how funding of research trials in the UK
and Europe is geared towards randomised trials of service delivery
interventions. This means the review may have a good deal of
applicability to service designs such as (and similar to) the UK NHS.
Third, while the mean age range of the people involved in these
studies may reflect the population who are largely aHected by long-
term conditions, it may also reflect bias in whom the clinicians
might also trust to know and manage their own condition.
This implies that this type of appointment system may not be
appropriate for all patients, particularly those with a new diagnosis
(although this has not been studied in the research included in this
review).
Fourth, variation in the quality of reporting of the intervention
makes it diHicult to know how to reliably interpret the findings
of the review. For example, the results of this review suggest
great variability in satisfaction of patients with the intervention.
This diHerence could be due to: poor reporting of the levels of
satisfaction between PIAS and consultant-led appointment groups;
a real diHerence between those with rheumatoid arthritis and those
with diHerent types of cancer (suggesting that the PIAS system
may not work for all long-term chronic conditions); diHerent tools/
bespoke sets of questions being used to ask patients about their
satisfaction with the service; or that particular elements of the
intervention have been used or are missing from those studies.
The reporting of interventions in detail is important, yet diHicult
with word restrictions placed on peer review publications and with
authors potentially being uncontactable at the time of the review.
Certainty of the evidence
The overall certainty of the evidence included in this review ranged
mainly from low to very low according to the GRADE classification
(Higgins 2011). This was due to the poor reporting of the studies,
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but even where authors were contacted, it was not always possible
to gain clarification of the study details, leading to a substantial
amount of uncertainty within the existing evidence surrounding
this intervention. For example, the evidence around anxiety,
depression and quality of life was downgraded to low certainty
due to the risk of bias identified within studies and the wide CIs
presented in the analyses. Service utilisation (contacts) evidence
was downgraded to low certainty due to serious indirectness and
diHiculties assessing the consistency and precision of the results.
Service utilisation (costs) evidence was downgraded to very-low
certainty due to risk of bias across studies, serious indirectness
and serious imprecision. The evidence around adverse events was
downgraded to low certainty due to risk of bias across studies and
serious consistency and imprecision and the evidence for patient
satisfaction was downgraded to low certainty due to risk of bias,
the indirectness related to how satisfaction was measured across
studies, and due to consistency and precision being diHicult to
assess.
This made the details of data analysis and attrition inconsistent
and diHicult to follow. When clearly reported, random sequence
generation and allocation concealment were areas of low risk of
bias, but for some studies this remained unclear. Blinding of the
participants and personnel would have not been possible with this
type of intervention.
Potential biases in the review process
This review reduced the likelihood of potential biases by following
the comprehensive guidelines set out in the Cochrane Handbook
for Systematic Reviews of Interventions (Higgins 2011). The review
outcomes were also broad so that we could be sure to capture
all the relevant research evidence. The review did not include
research conducted with children and did not include studies which
referred to patients 'self-management' without a description of the
intervention as in the Description of the intervention.
Agreements and disagreements with other studies or
reviews
The previous reviews in this area attempted to incorporate a wider
range of study design, but found only nine studies to include
between them and these studies were all based in the UK (Whear
2013a; Whear 2013b). Despite these diHerences, our review reports
similar findings, with uncertainty remaining a strong message
throughout.
A U T H O R S '   C O N C L U S I O N S
Implications for practice
Overall, this review provides low-certainty evidence that patient-
initiated appointment systems may have little or no impact on
the anxiety, depression and quality of life of people with chronic
conditions in secondary care. Other aspects of disease status and
experience also appear to show little or no diHerence between
patient-initiated and consultant-led appointment systems. The
impact of patient-initiated appointment systems on service
utilisation (contacts and costs) and adverse events was uncertain
compared to consultant-led appointment systems. There is also
some uncertainty as to the level of satisfaction experienced by
patients using this mode of care. This could be seen positively as
some evidence of no harm; however, clinicians should be cautious
in implementing this system within their care practices and should
be vigilant about which patients may benefit and be confident
and satisfied using the system (both within and across health
conditions). Care should be taken to record the impact on service
utilisation (including contact with professionals and financial costs)
as well as other service/care information, such as the number of
appointments not attended and the number of adverse events such
as relapses and recurrences.
Implications for research
Further research in this area would benefit from higher-
quality, better-reported and larger randomised trials with longer
endpoints. These trials would also benefit from standard
measurement and reporting of outcomes of common interest
such as quality of life, anxiety, depression, satisfaction with the
intervention, relapses/recurrences, and service utilisation contacts
and costs, as well as more consistent reporting of adverse events or
failures of the system.
Future research might also consider whether particular aspects
of the intervention are associated with eHectiveness such as the
role of the general practitioner (GP), use of extra educational
material or care management plans within the intervention and
the content of the initial consultation. Future research might
also consider benefits to particular populations such as those in
more rural/remote areas and those who have diHiculty attending
appointments due to disability, access to transport or other lack
of support services. DiHerences in service use or eHectiveness
between population characteristics such as gender, age, and length
of time living with their condition and type of condition would also
be worth exploring. Further investigation of all these components
and the mechanism of action will help to structure and maintain
a sustainable appointment system that is acceptable to patients
and health professionals. New areas of 'patient-initiated care' are
also developing (e.g. NCT02577224; Schougaard 2019), and would
be worth considering in the future of patient-initiated care and
experience across diHerent conditions.
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C H A R A C T E R I S T I C S   O F   S T U D I E S
Characteristics of included studies [ordered by study ID]
 
Methods Individual, single-centre prospective randomised trial, 24 months
Participants Netherlands; 1 teaching hospital (100 participants); COPD; 74 males, 26 females; mean age 69 years
CONT, 69 years INT
Interventions INT (n = 49): participant could call NP when experienced increase in symptoms such as dyspnoea,
cough, sputum, haemoptysis or thoracic pain. NP then followed protocol designed for study which in-
cluded taking a history from participant to assess urgency; if urgency low, appointment booked with
NP next day, if urgency high, NP could seek advice from pulmonologist and could book appointment
with pulmonologist within next few hours. Safety net – 1 fixed appointment per year.
CONT (n = 51): consultant- or NP-led (schedule NR/at discretion of pulmonologist), availability of emer-
gency appointments unclear.
Outcomes COPD symptoms scores: 6, 12, 24 months (CCQ)
Respiratory symptoms: 6, 12, 24 months (SGRQ)
Quality of life: 6, 12, 24 months (SF-36)
Time to first exacerbation: 24 months (medical notes and hospital records)
Number of participants with ≥ 1 exacerbation in primary and secondary care: 24 months (medical notes
and hospital records)
Visits to pulmonologists and NPs and GPs: 24 months (medical notes and hospital records)
Healthcare provider costs: 24 months (Dutch manual for costing studies and transformed to 2013 Eu-
ros)
Healthcare insurance costs: 24 months (diagnosis treatment combination of 2013 of the hospital)
Notes Funded by Isala Hospital, no conflicts of interest reported.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomised with computer minimisation programme to achieve balanced
groups for gender age (< 70 years or > 70 years), and predicted forced expirato-








High risk Participants could not be blinded.
Blinding of outcome as-
sessment (detection bias) 
All outcomes
High risk Self-reported questionnaires.
Berkhof 2014 
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Low risk ITT analysis.
Selective reporting (re-
porting bias)
Low risk All outcomes appeared to be reported.




Methods Randomised individual, multisite (4 sites) trial, 12 months
Participants UK, 4 hospital clinics (61 participants), breast cancer, women, mean age 65.34 years
Interventions INT (n = 30): participant to contact BCN by telephone if any problems/ as needed. Given written infor-
mation on signs and symptoms of recurrence. Safety net – yearly mammogram.
CONT (n = 31): consultant-led (schedule NR), availability of emergency appointments unclear.
Outcomes Health-related quality of life: 6 and 12 months (EORTC QLQ-C30)
Disease-specific health-related quality of life: 6 and 12 months (EORTC QLQ-BR23)
Psychological morbidity: 6 and 12 months (HADS)
Satisfaction: 6 and 12 months (bespoke tool)
Contact with health professional: 12 months (medical records)
Notes Source of funding and conflicts of interest NR.
Contacted authors for more information, no further data provided.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Random number list generated by staH.
Allocation concealment
(selection bias)





High risk Participants not blinded; all outcomes self-reported.
Blinding of outcome as-
sessment (detection bias) 
All outcomes




High risk 20% in CONT and 10% in INT lost to 'difficulties in recording' for satisfaction.
Unsure of numbers for EORTC outcome.
Brown 2002 
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Selective reporting (re-
porting bias)
Low risk All outcomes reported for all time points.
Other bias High risk Some participants not recommended to study due to staH opinion about suit-
ability which was not fully explained; 'presentation bias' as all women who
agreed to be part of the study may have felt more positively or may have been
more knowledgeable about the PIAS anyway, especially as many women re-




Methods Randomised, individual, multisite (2 sites) trial, 18 months
Participants Sweden; 2 Karolinska University Hospital outpatient clinics (131 participants); RA (who fulfilled the
American College of Rheumatology criteria for RA from 1987); 41 men, 90 females; median age 64 years
CONT, 65 years INT
Interventions INT (n = 64): participants to contact specialist nurse-led advice line as needed, appointment to be re-
ceived within 10 working days. Safety net – participant monitored by specialist nurse every 3 months
for the period of the study to assess disease activity.
CONT (n = 67): consultant-led clinics (schedule NR), safety net as above, emergency appointments
available.
Outcomes Tender and swollen joint counts: every 3, 6, 12 and 18 months (28-joint count according to the EULAR
handbook)
Disease activity: 3, 6, 12 and 18 months (DAS 28)
Number of appointments with rheumatologist: 3, 6, 12 and 18 months (hospital records)
Satisfaction with care: 3, 6, 12 and 18 months (VAS)
Confidence in care: 3, 6, 12 and 18 months (VAS)
General health: 3, 6, 12 and 18 months (VAS)
Pain: 3, 6, 12 and 18 months (VAS)
Erythrocyte sedimentation rate: 3, 6, 12 and 18 months (clinical tests)
C-reactive protein 3, 6, 12 and 18 months (clinical tests)
Proportion of participants with DAS 28: < 3.2 at 3, 6, 12 and 18 months (DAS 28)
Functional status: 3, 6, 12 and 18 months (HAQ)
Notes Source of funding: Forte (The Swedish Research Council for Health, Work Life and Welfare, grant num-
ber 2014–4238) and through the regional agreement on medical training and clinical research (ALF) be-
tween the Stockholm County Council and the Karolinska Institute. None declared.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated random-number sequence prepared by an independent
party.
Fredriksson 2016 
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Allocation concealment
(selection bias)






High risk Study nurses and participants were aware of the group assignment.
Blinding of outcome as-
sessment (detection bias) 
All outcomes





Low risk Used ITT analysis, report median and IQR and change from baseline for all out-
comes except for number of rheumatology appointments.
Selective reporting (re-
porting bias)
Low risk Appeared to report on all outcomes they intended to.




Methods Randomised, individual, single site trial, 12 months
Participants UK; 1 hospital clinic (290 participants); RA; 68 men, 222 women; mean age 63.1 years CONT, 65.4 years
INT
Interventions INT (n = 138): participant or GP to contact specialist nurse-led advice line as needed, appointment to be
received within 10 working days. Safety net – participant contacted by specialist nurse for review if not
been in contact within 1 year.
CONT (n = 152): consultant-led clinics (schedule NR), safety net as above, availability of emergency ap-
pointments unclear.
Outcomes Participant satisfaction: 12 months (PSQ-18 plus 5 additional locally relevant questions)
Service use: 12 months (patient records and reports)
Time and expense: 12 months (hospital records and clinical staH discussion)
Notes Funding – National Institute for Health Research Collaboration for leadership in Applied Health Re-
search and Care South West Peninsula, COI NR
Risk of bias
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High risk Blinding not possible.
Blinding of outcome as-
sessment (detection bias) 
All outcomes




High risk Some results only available for 58–64% of the sample and not reported why re-
sults missing; no ITT reported.
Selective reporting (re-
porting bias)
Low risk All outcomes reported.




Methods Randomised, individual, single site trial; median follow-up 16 months
Participants UK, 1 combined breast clinic (196 participants), breast cancer, women only, mean age NR
Interventions INT (n = 97): participant to contact clinic if any problems/as needed, appointment to be received within
5 working days. Safety net – yearly mammogram.
CONT (n = 96): consultant led every 3 months in first year from diagnosis, every 4 months in second
year, every 6 months 2–5 years and annually for ≥ 5 years. Emergency appointments available.
Outcomes Acceptability of intervention: annually from 6 months after study entry (MRC quality of life question-
naire + other questions)
Satisfaction of intervention: annually from 6 months after study entry (MRC quality of life questionnaire
+ other questions)
Interim events: 16 months (medical records)
Time and expense: 18 months (MRC quality of life questionnaire + other questions)
Notes Funding – MRC and Cancer Research Campaign, no conflicts of interest.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Details NR.
Allocation concealment
(selection bias)





Unclear risk Not blinded to allocation and some questionnaires self-reported. Unclear who
retrieved information from hospital records and if they were blinded.
Gulliford 1997 
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Blinding of outcome as-
sessment (detection bias) 
All outcomes
High risk Not blinded to allocation and some questionnaires self-reported. Unclear who




Unclear risk Details NR.
Selective reporting (re-
porting bias)
High risk MRC quality of life NR.




Methods Randomised, individual, multisite (3 sites) trial, 36 months
Participants Sweden, 3 urological departments (400 participants), prostate cancer, men only, mean age 75.8 years
Interventions INT (n = NR): participant to contact specialist nurse if any problems/as needed. Safety net – nurse tele-
phoned after 6 months if patient not been in contact.
CONT (n = NR): consultant led every 2–12 months, emergency appointments available, opportunity for
additional contact with urologist also available.
Outcomes Psychological morbidity: 6, 12, 18, 24 and 36 months (HADS)
Satisfaction with intervention: 6, 12, 18, 24 and 36 months (bespoke tool)
Contact with healthcare: 36 months (medical records and questionnaire)
Medical interventions and costs: 36 months (medical records and questionnaire)
Notes Funding – Dagmar-50 project of Swedish Government, Örebro Medical Centre Research Foundation
and the Örebro County Council Research Committee, COI NR.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Generation NR.
Allocation concealment
(selection bias)





High risk No-one blinded.
Blinding of outcome as-
sessment (detection bias) 
All outcomes
High risk Unclear who collected hospital data. Participants not blinded and outcomes
are self-reported.
Helgesen 2000 
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High risk High mortality; poor reporting of numbers at follow-up per group: 7 partici-




Low risk Data not reported at 6 and 18 months but reported for 12, 24 and 36 months.




Methods Randomised. individual, single site trial, 24, 48 and 72 months
Participants UK; 1 outpatient rheumatology clinic (209 participants); RA; 58 men 124 women; mean age 59 years
CONT, 57 years INT
Interventions INT (n = 105): participants contacted nurse-run help line if any problems/as needed. GP provided with
information leaflets and could also initiate hospital appointment. Participants could also ask for OT or
PT appointment (maximum wait 10 days). Safety net – 3 monthly questionnaire to assess clinical sta-
tus.
CONT (n = 104): consultant-led every 3–4 months, emergency appointments available.
Outcomes RA status: 24, 48 and 72 months (many clinical physiological measures)
Clinical and psychological status: every 3, 48 and 72 months (VAS, HAQ, AHI, HADS)
Self-efficacy and changes in medication: SF-36 added at 48, 60 and 72 months
Satisfaction with intervention: every 3 months (VAS)
Satisfaction and confidence with intervention: every 12 months at 12, 24, 36, 48 (VAS) (only reported at
48 months)
Resource use: 24 months (medical records, patient diaries and published unit cost data)
Contact with health professionals: 72 months (medical records)
Notes Funded by NHS Research and Development National Programme Grant. COI NR.
Contacted authors for more information, further data provided for all outcome measures.
Risk of bias
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Blinding of outcome as-
sessment (detection bias) 
All outcomes




Low risk Withdrawals and deaths reported and were similar for both groups.
Selective reporting (re-
porting bias)
High risk Only analysed those who completed 4/9 assessments.




Methods Randomised, individual, multisite (4 sites) trial, 10 months
Participants Denmark; 4 hospital gynaecology departments (212 participants); early-stage endometrial cancer;
women only; mean age 66.5 years CONT, 63.4 years INT
Interventions INT (n = 105): participants were instructed about 'alarm symptoms' that required examination, they
could telephone the project nurse to ask for a consultation (or be referred by GP), safety net – none.
CONT (n = 107): consultant-led every 4–6 months for 3 years, emergency appointments unclear.
Outcomes Fear of cancer recurrence: 3, 6 and 10 months (and 3 years in process, FCRI)
Clinical fear of cancer recurrence: 3, 6 and 10 months (and 3 years in process, FCRI > 16 on severity sub-
scale)
Primary care use: 3, 6 and 10 months (and 3 years in process, 2 bespoke questions)
Telephone contacts: 10 months (chart review)
Consultations at hospital: 10 months (chart review)
Notes High % of women declining to participate (95/309), only women who completed the first and fourth
questionnaires were included in analysis.
Funded by Danish Cancer Society, National Research Centre of Cancer Rehabilitation (University of
Southern Denmark), Region of Southern Denmark, and Odense University Hospital.
COI – none.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Participants randomly assigned following surgery using a computer-based sys-
tem, stratified according to healthcare centre. Randomisation was performed
centrally with a block size of 10 within each hospital.
Allocation concealment
(selection bias)




High risk Patients and healthcare providers could not be blinded to enrolment.
Jeppesen 2018 
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All outcomes
Blinding of outcome as-
sessment (detection bias) 
All outcomes
High risk Data analysts blinded to group assignment until all analyses were complet-
ed using non-identifying terms for the groups but participants had completed




Low risk Similar dropout from each group and no reported significant differences be-
tween 'responders' and 'non-responders' at baseline.
Selective reporting (re-
porting bias)
High risk Not all outcomes reported as per protocol.




Methods Randomised, cluster, multisite (19 sites with randomisation by treatment centre) trial, 12 months
Participants UK; 19 hospital outpatient clinics (700 participants); ulcerative colitis or Crohn's disease; 269 men, 366
women, mean age 46.34 years CONT, 44.37 years INT
Interventions INT (n = 297): participants could telephone hospital if any problems/as needed. Participants given ini-
tial consultation and a detailed guidebook about their condition and what symptoms to be aware of
and prepared a written self-management plan. Safety net – none.
CONT (n = 403): consultant-led appointments as usual (schedule NR), availability of emergency ap-
pointments unclear.
Outcomes Disease-related quality of life: 12 months (IBDQ)
Quality of life: 12 months (EQ-5D, HADS, SF-36, PEI)
Satisfaction: 12 months (bespoke questionnaire)
Interim events: 12 months (medical records and patient diaries)
Symptoms: 12 months (patient diaries)
Economic costs: 12 months (patient diaries and medical records, EQ-5D)
Notes Economic evaluation – health service resource use and cost effectiveness using EQ-5D.
Funded by NHS Research and Development Health Technology Assessment Programme.
COI NR.
Contacted authors for more information, further data provided for IBDQ and depression.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk The 19 remaining hospital sites were randomly ordered from 1 to 19 (by a sta-
tistician not associated with the study using a prepared sequence of random
numbers), and these numbers were randomly drawn out of a hat allocating
each hospital either to the CONT group (10 sites) or INT group (9 sites).
Kennedy 2003 
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Allocation concealment
(selection bias)
Low risk The 19 remaining hospital sites were randomly ordered from 1 to 19 (by a sta-
tistician not associated with the study using a prepared sequence of random
numbers), and these numbers were randomly drawn out of a hat allocating





High risk Participants not blinded.
Blinding of outcome as-
sessment (detection bias) 
All outcomes








Low risk All outcomes detailed in the methods section were reported.




Methods Randomised, individual, single-site trial, 52 weeks
Participants Denmark; 1 hospital (150 participants); psoriasis; 95 men, 55 women; mean age 47.4 years CONT, 51.5
years INT
Interventions INT (n = 73): participants were able to request a consultation when needed via a telephone helpline
managed by specialist nurses who could also provide advice and assistance. Laboratory tests every 12
weeks. Safety net – 1 scheduled annual appointment with dermatologist.
CONT (n = 77): consultant-led every 12–16 weeks plus laboratory tests as in INT group, emergency ap-
pointments available.
Outcomes Health-related quality of life: 52 weeks (DLQI)
Psychological well-being: 52 weeks (HADS)
Satisfaction with the system: 52 weeks (3 questions on Likert scale)
Appointment use due to psoriasis: 52 weeks (medical records)
Treatment safety: 12–16 weeks for 52 weeks (laboratory tests)
Clinical monitoring: 52 weeks (PASI, physiological clinical measurements)
Notes All participants interested had a mandatory information meeting to hear about the study. Patients had
to collect medication and have laboratory tests every 12 weeks (checked monthly by lead researcher).
The lead researcher provided face-to-face information to patients on their safety and recognising diffi-
culties/flare-ups and access to help through the helpline.
Patient adherence checked monthly. Patients who failed to attend their laboratory test or pick up med-
ication were telephoned and encouraged along. Patients who failed to adhere > 3 times were excluded
from the study.
Khoury 2018 
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Funded by Capital region of Denmark, Johannes Foghs Fond and The Danish National Psoriasis Asso-
ciation. COI: C.Z. has served as a scientific consultant for AbbVie, Almirall, Pfizer, Janssen-Cilag, Mer-
ck & Co., Inc., Eli Lilly, Takeda and Novartis, and as a clinical study investigator for AbbVie, LEO Phar-
ma, Amgen, Eli Lilly, Merck & Co., Inc., Takeda and Novartis. L.S. has received research grants from Pfiz-
er, Janssen-Cilag and LEO Pharma, and served as a scientific consultant for AbbVie, Almirall, Pfizer,
Janssen-Cilag, LEO Pharma, Eli Lilly, Celgene and Novartis, and as a clinical study investigator for Abb-
Vie, Amgen, Eli Lilly, LEO Pharma, Takeda and Novartis.
Contacted authors for more information, further data provided for DLQI, HADS and satisfaction with
the system.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomised at an individual level by a computer-generated algorithm, strati-
fied according to sex and medical treatment.
Allocation concealment
(selection bias)





High risk Blinding not feasible, which may have influenced self-reported outcomes such
as DLQI and HADS.
Blinding of outcome as-
sessment (detection bias) 
All outcomes




Low risk Very low levels of withdrawals or missing data but no ITT attempted.
Selective reporting (re-
porting bias)
High risk Protocol suggested outcomes were to be reported at 2 years; this article was
at 1 year and did not cover all the outcomes planned in the protocol. Patients
who failed to adhere more than 3 times were excluded from the analysis.




Methods Randomised, individual, single-site trial, 24 months
Participants UK; 1 hospital (112 participants); breast cancer; women only; mean age 60.5 years CONT, 60.7 years INT
Interventions INT (n = 56): participants to contact nurse-run helpline as needed. Participants also received 4 psychoe-
ducational sessions and a resource pack. Safety net – none.
CONT (n = 56): schedule NR. Participants also received same psychoeducational sessions but without
resource pack, availability of emergency appointments unclear.
Outcomes Anxiety and depression: 6, 12, 18 and 24 months (HADS)
Quality of life: 6, 12, 18 and 24 months (EORTC QLQ-C30 and EORTC QLQ-BR23)
Kirshbaum 2017 
Patient-initiated appointment systems for adults with chronic conditions in secondary care (Review)









Cochrane Database of Systematic Reviews
Notes All participants received 4 psychoeducational sessions (half-days over 4 weeks called 'Moving For-
ward') addressing the management and impact of breast cancer, breast reconstruction, lymphoedema,




Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not described.
Allocation concealment
(selection bias)





High risk Blinding could not be achieved due to the nature of the intervention and being
conducted on 1 hospital site.
Blinding of outcome as-
sessment (detection bias) 
All outcomes




Unclear risk Appropriate dealing with missing values was evident but no information on
how much missing data from each group, and quite likely missing data could
have been directly linked to the outcome being measured.
Selective reporting (re-
porting bias)
Low risk All recorded data seemed to be reported in tables.




Methods Randomised, individual, multisite (3 sites) trial, 60 months
Participants Sweden; 3 hospitals (264 participants); breast cancer; women only; mean age 58.8 years CONT, 60 years
INT
Interventions INT (n = 133): participant to telephone nurse if any problems/as needed. Nurse provided advice or
could seek assistance from a specialist and make further appointments. Safety net – yearly mammog-
raphy.
CONT (n = 131): consultant-led 4 times per year in first 2 years after surgery then twice per year up to 5
years then once per year thereafter, yearly mammography. Availability of emergency appointments un-
clear.
Outcomes Anxiety and depression: every 6 months to 3 years + 5 years (HADS)
Satisfaction and accessibility: every 6 months to 3 years + 5 years (SaaC)
Medical examinations, visits and telephone contacts: 60 months (medical records)
Koinberg 2004 
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Breast cancer-related unit costs: 60 months (lists of unit costs from 3 hospitals)
Contact with other physicians breast cancer-related: 60 months (medical records)
Number of breast cancer-related diagnostic procedures: 60 months (medical records)
Notes Participants attend an initial consultation with the nurse approximately 3 months after surgery, where
participant received information on recognising recurrence in breast, skin, axilla and scar tissue. Partic-
ipant returned to usual care after 3 years. Funded by the Cancer and Traffic Federation Sweden and the
County Council of Halland Sweden. COI NR.
Contacted authors for more information, further data provided for contacts with other physicians.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated randomisation.
Allocation concealment
(selection bias)






High risk Not possible for participants or personnel.
Blinding of outcome as-
sessment (detection bias) 
All outcomes





Unclear risk Group that was not analysed due to wrong intervention; otherwise all analyses
were ITT and all-cause mortality was the same in both groups.
Selective reporting (re-
porting bias)
High risk No data at 30 and 36 months.




Methods Randomised, individual, multisite (3 sites) trial, 12 months
Participants Finland; 3 outpatient clinics (122 participants); asthma; men 43, women 72; mean age 42.8 years CONT,
40.6 years INT
Interventions INT (n = 60): participant contacted nurse or doctor if peak expiratory flow fell below 85% and did not
reach optimal peak flow within 2 weeks or if peak expiratory flow fell below 70% optimal value. Partic-
ipants given personal education by trained nurses. Safety net – participants visited outpatient depart-
ment every 4 months.
CONT (n = 62): consultant-led appointment every 4 months. Participants were advised how to use their
inhalers correctly and given general information on their disease during the routine visits to the outpa-
tient department. Availability of emergency appointments unclear. Participants visited outpatient de-
partment every 4 months.
Lahdensuo 1996 
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Outcomes Days oH work, admissions to hospital, unscheduled visits to care and drug use: 12 months (medical
records, patient diaries, or both)
Lung function: 4, 8 and 12 months (spirometry and patient diaries)
Quality of life: 4, 8 and 12 months (selected components of the SGRQ)
Adverse events: 4, 8 and 12 months (medical records)
Notes Analysis based on 115 participants who had 24-month follow-up.
Funded by Suomen Astra Oy.
COI NR.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "The block randomisation method was used … randomisation lists
were prepared separately for each centre by computer."
Allocation concealment
(selection bias)






High risk Not possible.
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk While this trial was described in the methods as "single blind", we found no









Low risk Results for all outcomes mentioned in the methods were reported.




Methods Randomised, individual, multisite (2 sites, 3 arms) trial, 12 and 24 months
Participants Denmark; 2 hospital outpatient rheumatology clinics (287 participants in 3 arms, CONT and INT of in-
terest = 193); RA; 58 men, 135 women; mean age 61.1 years
Interventions INT (n = 96): participant (or GP) to contact nurse by telephone for advice or appointment as necessary.
GP managed medication according to algorithm from rheumatology department. Safety net – annual
hospital review.
CONT (n = 97): consultant-led every 3 months to 1 year depending on clinician judgement. Emergency
appointments available.
Primdahl 2012 
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Outcomes Disease activity: baseline, 12 and 24 months (DAS 28 CRP)
Disability: baseline, 12 and 24 months (HAQ Danish version)
Pain and fatigue: baseline and 12 months (VAS)
Self-efficacy: baseline, 3, 12 and 24 months (RASE and ASES)
Satisfaction/confidence in care: baseline, 12 and 24months (VAS)
Disease activity: every 3 months (Rheumatoid Arthritis Disease Activity Index)
Quality of life: baseline, 12 and 24 (EQ-5D-5L)
Resource use and costs: baseline, 12 and 24 months (questionnaires, hourly rates and medical records)
Notes All participants received 20 × 3-hour sessions from a rheumatologist, an OT, PT and a nurse on how to
manage disease-related problems in everyday life and to know when to seek help (details on page 122).
Participants were allocated after receiving this education. Participants in INT group were contacted by
nurses if their disease activity, disability or adverse events scores rose by more than 20%.
Funded by University of Southern Denmark, Sygehus Sonderjylland, region of Southern Denmark, Hans
Christensen's Memorial Foundation, Gigtforeningen and King Christian X's Hospital for Rheumatic Dis-
eases.
COI NR.
Contacted authors for more information, further data provided for all outcome measures.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated randomisation.
Allocation concealment
(selection bias)
Low risk Distributed in closed envelopes by secretary who knew the allocation (we be-
lieve). Therefore, it is possible they let others know, although we consider it





High risk Could not be blinded and measures were self-reported.
Blinding of outcome as-
sessment (detection bias) 
All outcomes




Low risk 16 participants leO in first year of study, unclear from which group.
Selective reporting (re-
porting bias)
Low risk All outcomes reported at all time points.




Patient-initiated appointment systems for adults with chronic conditions in secondary care (Review)









Cochrane Database of Systematic Reviews
Methods Randomised, individual, multisite (4 site) trial, 14 months (median follow-up)
Participants UK; 4 hospital gastroenterology departments (203 participants); ulcerative colitis; 98 men, 105 women;
mean age 48 years CONT, 49 years INT
Interventions INT (n = 101): participants to contact helpline for clinical advice or appointments as necessary. Partic-
ipants also received a personalised guided self-management regimen. Participants requiring routine
monitoring of blood or urine were asked to attend their primary-care centre. Safety net – none.
CONT (n = 102): consultant-led (schedule NR), availability of emergency appointments unclear.
Outcomes Time between symptom development and start of treatment (patient diaries and medical records)
Number of consultations (primary and secondary care): 14 months (patient diaries and medical
records)
Cost to patient: 14 months (patient diaries and medical records)
Acceptability of intervention: 14 months (patient diaries)
Quality of life: baseline and 14 months (IBDQ)
Notes Estimated costs to participants from expenditure on public transport, or motoring costs (by use of data
from the Automobile Association, UK). Time spent visiting a doctor was calculated as the time between
participants leaving and returning home or to work.
Funded by MRC Training Fellowship in Health Services Research.
COI NR.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)




Low risk Subsequent participants were allocated by the process of minimisation which





High risk Blinding of study personnel not described.
Blinding of outcome as-
sessment (detection bias) 
All outcomes




Low risk Reasons for loss to follow-up were given for both groups, which were similar
across groups (more lost from CONT group than INT group).
Selective reporting (re-
porting bias)
High risk All outcomes mentioned in methods section were reported (although full de-
tails were not given for non-significant results).
Other bias Low risk No obvious signs of other bias.
Robinson 2001 
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Methods Randomised, individual, single-site trial, 18 months
Participants UK, 1 specialist breast unit (237 participants), breast cancer, women only, mean age 57 years
Interventions INT (n = 107): participants to contact nurse specialist by telephone as necessary, safety net – yearly
mammogram.
CONT (n = 107): nurse- or consultant-led every 6 months, received yearly mammograms, availability of
emergency appointments unclear.
Outcomes Psychological morbidity: baseline, 9 and 18 months (GHQ 12)
Quality of life: baseline, 9 and 18 months (FACT-B)
Recurrences: 18 months (medical records)
Fear of recurrence: baseline, 9 and 18 months (3 item fear questionnaire)
Isolation: 9 and 18 months (1 question)
Notes Funded by Wessex Cancer Trust.
No COI.
Contacted authors for more information, further data provided for all outcome measures.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated random assignment.
Allocation concealment
(selection bias)





High risk Participants were informed of allocation following randomisation externally
and in sealed envelopes.
Blinding of outcome as-
sessment (detection bias) 
All outcomes




High risk We do not know which group the participants lost to follow-up were in and
they were excluded from analysis.
Selective reporting (re-
porting bias)
Low risk All outcomes reported at all time points.
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Methods Randomised, individual, multisite (2 sites) trial, 24 months
Participants UK, 2 district general hospitals (180 participants), inflammatory bowel disease, sex NR, mean age NR
Interventions INT (n = 88): participants to contact GP or hospital for advice or appointments as necessary, initial care
move back to GP so GP could also contact hospital on behalf of patient. Safety net – review appoint-
ment at 24 months and regular colonoscopy for those who needed it.
CONT (n = 92): consultant-led (schedule NR), emergency appointments available.
Outcomes Quality of life: 6, 12, 18 and 24 months (SF-36 and IBDQ)
Resource use: 24 months (patient questionnaires and medical records)
Patient and GP satisfaction and preferences: 24 months (unspecified questionnaire)
Notes Funded by NHS Research and Development Primary/Secondary Care interface Programme with sup-




Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)




Low risk Allocation lists held securely by independent researcher in each centre. When






High risk No blinding described.
Blinding of outcome as-
sessment (detection bias) 
All outcomes
High risk Self-reported questionnaires, but unclear if staH who collected information




Low risk Reminders sent to non-respondents for questionnaires, unclear if any were un-
returned. 5 participants withdrew. Number of withdrawals and uncompleted
questionnaires described for each group. Analysis by intention to follow-up.
Selective reporting (re-
porting bias)
Low risk All outcomes reported.
Other bias Unclear risk Impact of GP involvement in intervention unclear.
Williams 2000 
AHI: Arthritis Helplessness Index; ASES: Arthritis Self-EHicacy Scale; BCN: breast care nurse; CCQ: Clinical COPD Questionnaire; COI: conflict
of interest; CONT: control group; COPD: chronic obstructive pulmonary disease; DAS 28: Disease Activity Scale; DLQI: Dermatology Life
Quality Index; EORTC QLQ: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire; EORTC QLQ-C30: 30-
item EORTC QLQ; EORTC QLQ-BR23: 23-item breast-specific EORTC QLQ; EQ-5D: Euro Qol 5D; EQ-5D-5L: 5-level Euro Qol; EULAR: European
League Against Rheumatism; FACT-B: Functional Assessment for Cancer Therapy – Breast; FCRI: Fear of Cancer Recurrence Inventory;
GHQ: General Health Questionnaire; GP: general practitioner; HADS: Hospital Anxiety and Depression Scale; HAQ: Health Assessment
Questionnaire; IBDQ: Inflammatory Bowel Disease Questionnaire; INT: intervention group; IQR: interquartile range; ITT: intention-to-
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treat; MRC: Medical Research Council; n: number of participants; NP: nurse practitioner; NR: not reported; OT: occupational therapy/
ist; PASI: Psoriasis Area and Severity Index; PEI: Patient Enablement Instrument; PIAS: patient-initiated appointment system; PSQ-18:
Patient Satisfaction Questionnaire; PT: physiotherapy/ist; RA: rheumatoid arthritis; RASE: Rheumatoid Arthritis Self-EHicacy Scale; SaaC:
Satisfaction and accessibility Scale; SF-36: 36-item Short Form; SGRQ: St George's Respiratory Questionnaire; VAS: visual analogue scale.
 
Characteristics of excluded studies [ordered by study ID]
 
Study Reason for exclusion
Adams 2009 Wrong study design.
Arnaud 1997 Wrong study design.
Booth 2001 Wrong study design.
Bourbeau 2003 Wrong intervention.
Coenen 2017 Wrong study design.
Dent 2011 Wrong study design.
Emery 2014a Wrong intervention.
Emery 2014b Wrong intervention.
Emery 2017 Wrong intervention.
Fournier 2015 Wrong population/setting.
Hesselink 2011 Wrong intervention.
Hewlett 2005 Wrong study design.
Lawlor 2009 Wrong study design.
McBain 2014a Wrong intervention.
McBain 2014b Wrong intervention.
McBain 2015 Wrong intervention.
Ndosi 2011 Wrong intervention.
Paudyal 2012 Wrong study design.
Pope 2005 Wrong study design.
Pope 2014 Wrong study design.
Rogers 2004 Wrong study design.
Sands 2009 Wrong study design.
Schougaard 2019 Wrong intervention.
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Characteristics of ongoing studies [author-defined order]
 
Trial name or title An RCT of a patient-initiated treatment service for BEB and HFS
Methods Randomised controlled trial
Participants Adults with a diagnosis of hemifacial spasm or blepharospasm, attending a hospital-based botu-
linum toxin clinic at Moorfields Eye Hospital NHS Foundation Trust, who are stable on botulinum
toxin treatment, defined as receiving toxin treatment at stable doses over 2 previous cycles and
free from adverse effects.
Interventions Participants will initiate their own treatment during the 9 months of the trial. They will receive in-
formation about when and how to initiate an appointment. Contact details for the service will be
provided along with information on how quickly an appointment will be made, with whom and the
procedure in the case of an emergency. All participants requesting an appointment will be booked
into the next available slot within the twice weekly ring-fenced nurse-led clinics. Any subsequent
scheduled appointments will be cancelled and all future treatment will be initiated by the patient.
Outcomes Disease severity, disability, patient satisfaction, adverse effects, confidence in system of care, qual-
ity of life, mood, Illness perceptions, treatment beliefs, acceptability and cost effectiveness.
Starting date August 2015




BEB: benign essential blepharospasm; HFS: hemifacial spasm; RCT: randomised controlled trial.
 
 
D A T A   A N D   A N A L Y S E S
 
Comparison 1.   Patient-initiated appointment systems versus consultant-led appointment systems





Statistical method Effect size
1 Patient outcomes: anxiety
(HADS lower score = better 0–
21) (12–24 months)
5   Odds Ratio (Random, 95% CI) 0.87 [0.68, 1.12]
1.1 Cancer 3   Odds Ratio (Random, 95% CI) 0.94 [0.55, 1.59]
1.2 Psoriasis 1   Odds Ratio (Random, 95% CI) 0.89 [0.64, 1.23]
1.3 Rheumatoid arthritis 1   Odds Ratio (Random, 95% CI) 0.70 [0.36, 1.36]
2 Patient outcomes: depres-
sion (HADS lower score = bet-
ter 0–21) (9–24months)
6   Odds Ratio (Random, 95% CI) 0.79 [0.51, 1.23]
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Statistical method Effect size
2.1 Cancer 3   Odds Ratio (Random, 95% CI) 0.80 [0.23, 2.71]
2.2 Inflammatory bowel dis-
ease
1   Odds Ratio (Random, 95% CI) 0.74 [0.34, 1.63]
2.3 Psoriasis 1   Odds Ratio (Random, 95% CI) 1.0 [0.72, 1.38]
2.4 Rheumatoid arthritis 1   Odds Ratio (Random, 95% CI) 0.39 [0.16, 0.96]
3 Patient outcomes: quality of
life (12–18 months)
7 1486 Std. Mean Difference (IV, Random, 95% CI) 0.12 [-0.00, 0.25]
3.1 Cancer 2 296 Std. Mean Difference (IV, Random, 95% CI) -0.07 [-0.33, 0.20]
3.2 Asthma 1 115 Std. Mean Difference (IV, Random, 95% CI) 0.47 [0.10, 0.84]
3.3 Inflammatory bowel dis-
ease
2 735 Std. Mean Difference (IV, Random, 95% CI) 0.15 [0.00, 0.29]
3.4 Psoriasis 1 147 Std. Mean Difference (IV, Random, 95% CI) -0.01 [-0.33, 0.31]
3.5 Rheumatoid arthritis 1 193 Std. Mean Difference (IV, Random, 95% CI) 0.21 [-0.07, 0.50]
4 Rheumatoid arthritis: dis-
ease activity (VAS and DAS 12–
24 months)
2 375 Std. Mean Difference (IV, Random, 95% CI) -0.21 [-0.41, -0.01]
5 Rheumatoid arthritis: self-ef-
ficacy (ASES 12–24 months)
2 375 Mean Difference (IV, Fixed, 95% CI) 4.95 [0.57, 9.34]
6 Rheumatoid arthritis: pain
(VAS 12–24 months)
2 375 Mean Difference (IV, Fixed, 95% CI) -0.71 [-1.17, -0.26]
7 Rheumatoid arthritis: dis-
ability (HAQ 12–24 months)
2 375 Mean Difference (IV, Fixed, 95% CI) -0.06 [-0.19, 0.06]
8 Rheumatoid arthritis: patient
satisfaction
2 375 Std. Mean Difference (IV, Random, 95% CI) 0.05 [-0.41, 0.52]
9 Service utilisation (contacts)     Other data No numeric data
10 Service utilisation (costs)     Other data No numeric data
11 Missed appointments 2 599 Mean Difference (IV, Fixed, 95% CI) -0.27 [-0.42, -0.12]
12 Adverse event: relapses
(12–60 months)
3 888 Mean Difference (IV, Random, 95% CI) -0.20 [-0.54, 0.14]
12.1 Inflammatory bowel dis-
ease
2 624 Mean Difference (IV, Random, 95% CI) -0.4 [-0.72, -0.08]
12.2 Cancer 1 264 Mean Difference (IV, Random, 95% CI) 0.03 [-0.08, 0.14]
13 Patient satisfaction     Other data No numeric data
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Statistical method Effect size
13.1 Rheumatoid arthritis     Other data No numeric data
13.2 Inflammatory bowel dis-
ease
    Other data No numeric data
13.3 Cancer     Other data No numeric data
13.4 Psoriasis     Other data No numeric data
14 Chronic obstructive pul-
monary disease: other out-
comes
    Other data No numeric data
15 Cancer: other outcomes     Other data No numeric data
16 Inflammatory bowel dis-
ease: other outcomes
    Other data No numeric data
17 Psoriasis: other outcomes     Other data No numeric data
18 Rheumatoid arthritis: other
outcomes
    Other data No numeric data
19 Asthma: other outcomes     Other data No numeric data
 
 
Analysis 1.1.   Comparison 1 Patient-initiated appointment systems versus consultant-led appointment
systems, Outcome 1 Patient outcomes: anxiety (HADS lower score = better 0–21) (12–24 months).






Odds Ratio Weight Odds Ratio
  N N (SE) IV, Random, 95% CI   IV, Random, 95% CI
1.1.1 Cancer  
Helgesen 2000 0 0 -0.2 (0.445) 8.5% 0.79[0.33,1.89]
Kirshbaum 2017 0 0 -0.1 (0.482) 7.24% 0.92[0.36,2.37]
Koinberg 2004 0 0 0.1 (0.468) 7.67% 1.16[0.46,2.89]
Subtotal (95% CI)       23.41% 0.94[0.55,1.59]
Heterogeneity: Tau2=0; Chi2=0.35, df=2(P=0.84); I2=0%  
Test for overall effect: Z=0.24(P=0.81)  
   
1.1.2 Psoriasis  
Khoury 2018 0 0 -0.1 (0.165) 61.74% 0.89[0.64,1.23]
Subtotal (95% CI)       61.74% 0.89[0.64,1.23]
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=0.7(P=0.48)  
   
1.1.3 Rheumatoid arthritis  
Hewlett 2000 0 0 -0.3 (0.337) 14.86% 0.7[0.36,1.36]
Subtotal (95% CI)       14.86% 0.7[0.36,1.36]
Heterogeneity: Not applicable  
Favours patient-initiated 20.5 1.50.7 1 Favours consultant-led
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Odds Ratio Weight Odds Ratio
  N N (SE) IV, Random, 95% CI   IV, Random, 95% CI
Test for overall effect: Z=1.04(P=0.3)  
   
Total (95% CI)       100% 0.87[0.68,1.12]
Heterogeneity: Tau2=0; Chi2=0.84, df=4(P=0.93); I2=0%  
Test for overall effect: Z=1.07(P=0.29)  
Test for subgroup differences: Chi2=0.49, df=1 (P=0.78), I2=0%  
Favours patient-initiated 20.5 1.50.7 1 Favours consultant-led
 
 
Analysis 1.2.   Comparison 1 Patient-initiated appointment systems versus consultant-led appointment
systems, Outcome 2 Patient outcomes: depression (HADS lower score = better 0–21) (9–24months).






Odds Ratio Weight Odds Ratio
  N N (SE) IV, Random, 95% CI   IV, Random, 95% CI
1.2.1 Cancer  
Helgesen 2000 0 0 0.6 (0.547) 12.85% 1.82[0.62,5.31]
Kirshbaum 2017 0 0 -1.2 (0.879) 5.85% 0.29[0.05,1.62]
Koinberg 2004 0 0 -0.6 (1.14) 3.64% 0.53[0.06,4.91]
Subtotal (95% CI)       22.34% 0.8[0.23,2.71]
Heterogeneity: Tau2=0.51; Chi2=3.49, df=2(P=0.17); I2=42.68%  
Test for overall effect: Z=0.36(P=0.72)  
   
1.2.2 Inflammatory bowel disease  
Kennedy 2003 0 0 -0.3 (0.403) 19.69% 0.74[0.34,1.63]
Subtotal (95% CI)       19.69% 0.74[0.34,1.63]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.75(P=0.45)  
   
1.2.3 Psoriasis  
Khoury 2018 0 0 0 (0.165) 41.31% 1[0.72,1.38]
Subtotal (95% CI)       41.31% 1[0.72,1.38]
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
1.2.4 Rheumatoid arthritis  
Hewlett 2000 0 0 -0.9 (0.458) 16.65% 0.39[0.16,0.96]
Subtotal (95% CI)       16.65% 0.39[0.16,0.96]
Heterogeneity: Not applicable  
Test for overall effect: Z=2.06(P=0.04)  
   
Total (95% CI)       100% 0.79[0.51,1.23]
Heterogeneity: Tau2=0.1; Chi2=7.51, df=5(P=0.19); I2=33.46%  
Test for overall effect: Z=1.05(P=0.3)  
Test for subgroup differences: Chi2=3.98, df=1 (P=0.26), I2=24.67%  
Favours patient-initiated 100.1 50.2 20.5 1 Favours consultant-led
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Analysis 1.3.   Comparison 1 Patient-initiated appointment systems versus consultant-
led appointment systems, Outcome 3 Patient outcomes: quality of life (12–18 months).
Study or subgroup Patient-initiated Consultant-led Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
1.3.1 Cancer  
Kirshbaum 2017 39 69.4 (21.5) 43 75 (20.3) 7.29% -0.27[-0.7,0.17]
Sheppard 2009 107 165.1 (25.7) 107 164.4 (26.7) 15.57% 0.03[-0.24,0.29]
Subtotal *** 146   150   22.87% -0.07[-0.33,0.2]
Heterogeneity: Tau2=0.01; Chi2=1.26, df=1(P=0.26); I2=20.37%  
Test for overall effect: Z=0.49(P=0.62)  
   
1.3.2 Asthma  
Lahdensuo 1996 56 16.6 (15.9) 59 8.4 (18.4) 9.53% 0.47[0.1,0.84]
Subtotal *** 56   59   9.53% 0.47[0.1,0.84]
Heterogeneity: Not applicable  
Test for overall effect: Z=2.5(P=0.01)  
   
1.3.3 Inflammatory bowel disease  
Kennedy 2003 236 172.3 (36.6) 296 167.7 (37.5) 26.4% 0.12[-0.05,0.3]
Robinson 2001 101 189 (28) 102 183 (28) 14.95% 0.21[-0.06,0.49]
Subtotal *** 337   398   41.35% 0.15[0,0.29]
Heterogeneity: Tau2=0; Chi2=0.29, df=1(P=0.59); I2=0%  
Test for overall effect: Z=2(P=0.05)  
   
1.3.4 Psoriasis  
Khoury 2018 72 1.6 (20.4) 75 1.8 (20.8) 11.83% -0.01[-0.33,0.31]
Subtotal *** 72   75   11.83% -0.01[-0.33,0.31]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.06(P=0.95)  
   
1.3.5 Rheumatoid arthritis  
Primdahl 2012 96 0.8 (0.2) 97 0.7 (0.2) 14.42% 0.21[-0.07,0.5]
Subtotal *** 96   97   14.42% 0.21[-0.07,0.5]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.48(P=0.14)  
   
Total *** 707   779   100% 0.12[-0,0.25]
Heterogeneity: Tau2=0.01; Chi2=8.43, df=6(P=0.21); I2=28.84%  
Test for overall effect: Z=1.92(P=0.06)  
Test for subgroup differences: Chi2=6.48, df=1 (P=0.17), I2=38.31%  
Favours consultant-led 0.50.25-0.5 -0.25 0 Favours patient-initiated
 
 
Analysis 1.4.   Comparison 1 Patient-initiated appointment systems versus consultant-led
appointment systems, Outcome 4 Rheumatoid arthritis: disease activity (VAS and DAS 12–24 months).
Study or subgroup Patient-initiated Consultant-led Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Hewlett 2000 93 3 (2.3) 89 3.5 (2.3) 48.57% -0.19[-0.48,0.1]
Primdahl 2012 96 2.4 (1.1) 97 2.7 (1.1) 51.43% -0.23[-0.51,0.05]
   
Total *** 189   186   100% -0.21[-0.41,-0.01]
Favours patient-initiated 10.5-1 -0.5 0 Favours consultant-led
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Study or subgroup Patient-initiated Consultant-led Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Heterogeneity: Tau2=0; Chi2=0.03, df=1(P=0.85); I2=0%  
Test for overall effect: Z=2.03(P=0.04)  
Favours patient-initiated 10.5-1 -0.5 0 Favours consultant-led
 
 
Analysis 1.5.   Comparison 1 Patient-initiated appointment systems versus consultant-led
appointment systems, Outcome 5 Rheumatoid arthritis: self-e;icacy (ASES 12–24 months).
Study or subgroup Patient-initiated Consultant-led Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
Hewlett 2000 93 64 (21.4) 89 56.2 (23.8) 44.4% 7.75[1.17,14.33]
Primdahl 2012 96 80.8 (20.6) 97 78.1 (21.1) 55.6% 2.72[-3.16,8.6]
   
Total *** 189   186   100% 4.95[0.57,9.34]
Heterogeneity: Tau2=0; Chi2=1.25, df=1(P=0.26); I2=19.83%  
Test for overall effect: Z=2.21(P=0.03)  
Favours consultant-led 105-10 -5 0 Favours patient-initiated
 
 
Analysis 1.6.   Comparison 1 Patient-initiated appointment systems versus consultant-
led appointment systems, Outcome 6 Rheumatoid arthritis: pain (VAS 12–24 months).
Study or subgroup Patient-initiated Consultant-led Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
Hewlett 2000 93 3.9 (2.4) 89 5 (2.3) 44.45% -1.07[-1.76,-0.38]
Primdahl 2012 96 1.9 (2.1) 97 2.4 (2.3) 55.55% -0.43[-1.05,0.19]
   
Total *** 189   186   100% -0.71[-1.17,-0.26]
Heterogeneity: Tau2=0; Chi2=1.84, df=1(P=0.17); I2=45.74%  
Test for overall effect: Z=3.05(P=0)  
Favours patient-initiated 21-2 -1 0 Favours consultant-led
 
 
Analysis 1.7.   Comparison 1 Patient-initiated appointment systems versus consultant-
led appointment systems, Outcome 7 Rheumatoid arthritis: disability (HAQ 12–24 months).
Study or subgroup Patient-initiated Consultant-led Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
Hewlett 2000 93 1.3 (0.7) 89 1.3 (0.7) 37.38% -0.09[-0.29,0.11]
Primdahl 2012 96 0.4 (0.5) 97 0.5 (0.6) 62.62% -0.05[-0.2,0.1]
   
Total *** 189   186   100% -0.06[-0.19,0.06]
Heterogeneity: Tau2=0; Chi2=0.1, df=1(P=0.76); I2=0%  
Test for overall effect: Z=1.05(P=0.3)  
Favours patient-initiated 0.50.25-0.5 -0.25 0 Favours consultant-led
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Analysis 1.8.   Comparison 1 Patient-initiated appointment systems versus consultant-
led appointment systems, Outcome 8 Rheumatoid arthritis: patient satisfaction.
Study or subgroup Patient-initiated Consultant-led Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Hewlett 2000 93 8.2 (2) 89 7.6 (2.1) 49.69% 0.29[-0,0.58]
Primdahl 2012 96 77.9 (23.8) 97 82.1 (21.3) 50.31% -0.18[-0.47,0.1]
   
Total *** 189   186   100% 0.05[-0.41,0.52]
Heterogeneity: Tau2=0.09; Chi2=5.22, df=1(P=0.02); I2=80.85%  
Test for overall effect: Z=0.22(P=0.83)  
Favours consultant-led 0.50.25-0.5 -0.25 0 Favours patient-initiated
 
 
Analysis 1.9.   Comparison 1 Patient-initiated appointment systems versus




Person-years Total contacts Patient-ini-
tiated n
Person years Total contacts Rate ratio Contacts
covered






60 90 185 61 92 165 0.87 Consultant ap-
pointments on-
ly
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Person-years Total contacts Patient-ini-
tiated n
Person years Total contacts Rate ratio Contacts
covered














59 59 59 56 56 28 2.00 Outpatient vis-
its only





Robinson 2001 102 119 344 101 118 89 3.83 Booked clinic
appointments
Sheppard 2009 112 168 90 112 168 92 0.98 Specialist nurs-
es and GPs
contacts







Analysis 1.10.   Comparison 1 Patient-initiated appointment systems versus
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Analysis 1.11.   Comparison 1 Patient-initiated appointment systems versus
consultant-led appointment systems, Outcome 11 Missed appointments.
Study or subgroup Consultant-led Patient-initiated Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
Kennedy 2003 206 1.8 (2.2) 246 2.2 (2.5) 12.22% -0.4[-0.83,0.03]
Khoury 2018 72 0.1 (0.5) 75 0.3 (0.5) 87.78% -0.25[-0.41,-0.09]
   
Total *** 278   321   100% -0.27[-0.42,-0.12]
Favours patient-initiated 0.50.25-0.5 -0.25 0 Favours consultant-led
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Study or subgroup Consultant-led Patient-initiated Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
Heterogeneity: Tau2=0; Chi2=0.41, df=1(P=0.52); I2=0%  
Test for overall effect: Z=3.46(P=0)  
Favours patient-initiated 0.50.25-0.5 -0.25 0 Favours consultant-led
 
 
Analysis 1.12.   Comparison 1 Patient-initiated appointment systems versus consultant-
led appointment systems, Outcome 12 Adverse event: relapses (12–60 months).
Study or subgroup Patient-initiated Consultant-led Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
1.12.1 Inflammatory bowel disease  
Kennedy 2003 206 1.8 (2.2) 246 2.2 (2.5) 27.58% -0.4[-0.83,0.03]
Robinson 2001 87 1.5 (1.5) 85 1.9 (1.7) 25.07% -0.4[-0.88,0.08]
Subtotal *** 293   331   52.65% -0.4[-0.72,-0.08]
Heterogeneity: Tau2=0; Chi2=0, df=1(P=1); I2=0%  
Test for overall effect: Z=2.44(P=0.01)  
   
1.12.2 Cancer  
Koinberg 2004 133 0.2 (0.5) 131 0.1 (0.5) 47.35% 0.03[-0.08,0.14]
Subtotal *** 133   131   47.35% 0.03[-0.08,0.14]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.53(P=0.6)  
   
Total *** 426   462   100% -0.2[-0.54,0.14]
Heterogeneity: Tau2=0.06; Chi2=6.14, df=2(P=0.05); I2=67.42%  
Test for overall effect: Z=1.13(P=0.26)  
Test for subgroup differences: Chi2=6.14, df=1 (P=0.01), I2=83.71%  
Favours patient-initiated 0.50.25-0.5 -0.25 0 Favours consultant-led
 
 
Analysis 1.13.   Comparison 1 Patient-initiated appointment systems versus










P value (95% CI)
Rheumatoid arthritis
Fredriksson 2016 Satisfaction with
care at 18 months
(mean change from
baseline)
64 1 67 1 0.47
Goodwin 2016 Satisfaction with ser-
vice at 12 months –
(mean score)
138 100 152 80 0.002
Inflammatory bowel disease
Kennedy 2003 Satisfaction with
hospital visit (mean
score at 12 months
from patient diary)
64 54.6 (SD 8.5) 132 53.6 (SD 9.1) 0.62 (–3.67 to 6.03)
Robinson 2001 Acceptability – pre-
ferred PIAS interven-
tion (at 14 months)
86 71 (82) 85 80 (95) NR
Williams 2000 Acceptability – pre-
ferred PIAS interven-
tion at (24 months)
81 69 (85) 83 34 (41) < 0.01
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P value (95% CI)
Cancer
Brown 2002 Satisfaction with al-
located intervention
(at 6 months)
28 26 (93) 24 24 (100) NR
Gulliford 1997 Acceptibility (% pre-
ferring intervention)
97 11 96 6 NR
Helgesen 2000 Reporting deficient
outpatient service
(at 36 months)
NR NR (6.6) NR NR (4.9) NR
Koinberg 2004 Satisfied with med-
ical centre (SaaC at
60 months)
133 122 (91.6) 131 130 (98.9) ns
Psoriasis
Khoury 2018 Satisfaction with
overall care (at 12
months)
72 3.6 (0.1) 75 3.5 (0.1) P = 0.75 (mean
change difference
between groups




Analysis 1.14.   Comparison 1 Patient-initiated appointment systems versus consultant-led
appointment systems, Outcome 14 Chronic obstructive pulmonary disease: other outcomes.











P value (95% CI)




naire range 0–6 low-




40 0.33 (± 0.11) 29 0.53 (± 0.13) 0.24 (–0.55 to 0.14)








MCID of SGRQ total
score = 4)
38 5.0 (± 2.2) 30 6.4 (± 2.4) 0.67 (–7.9 to 5.1)
Berkhof 2014 Time to exacerba-
tion (median no. of
days)
49 307 (± 61.6) 51 335 (± 60.2) 0.40
 
 
Analysis 1.15.   Comparison 1 Patient-initiated appointment systems versus










P value (95% CI)
Gulliford 1997 % reassured with
service (at 16
months)
97 88 96 94 NR
Gulliford 1997 — — — — — —
Helgesen 2000 Accessibility (% re-
porting service in-
200 8.6 200 7.3 RR 1.18 (0.46 to 3.03)
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P value (95% CI)
accessible by tele-
phone 36 months)
Helgesen 2000 — — — — — —
Jeppesen 2018 Fear of cancer recur-
rence at 10 months
(mean (SD))
105 43.4 (26.5) 107 40.5 (28.5) 0.02
Jeppesen 2018 Clinical fear of recur-
rence at 10 months
(%)
105 17.7 107 22.1 0.89
Koinberg 2004 Accessibility by tele-
phone at 60 months
(%)
133 100 131 96.5 ns
Koinberg 2004 — — — — — —
Sheppard 2009 Fear of recurrence
at 18 months (score
from 3 questions -
mean)
107 5.6 107 5.0 0.066
Sheppard 2009 Isolation (% felt iso-
lated)
107 14 107 9 0.245
 
 
Analysis 1.16.   Comparison 1 Patient-initiated appointment systems versus consultant-
led appointment systems, Outcome 16 Inflammatory bowel disease: other outcomes.











Kennedy 2003 Enablement after
initial consultation
260 4.0 (3.9) 352 3.0 (3.9) 0.026 (0.12 to 1.68)
Kennedy 2003 Delay before starting
treatment (% within
1 day)
81 49.7 109 50.6 0.95 (–0.52 to 0.49)
Kennedy 2003 Appointments made
by patient (% at
least 1 self-made ap-
pointment)
144 43 250 22 < 0.001 (1.63 to 4.46)
Robinson 2001 Time to symptom
treatment (hours)
101 14.8 102 49.6 < 0.0001
Robinson 2001 Cost to patient (GBP)
at 14 months
101 0.86 102 8.92 < 0.0001
Robinson 2001 — — — — — —
 
 
Analysis 1.17.   Comparison 1 Patient-initiated appointment systems versus










p value or mean
di; (95% CI)
Khoury 2018 Missed medica-
tion collection (at
12mths)
72 11 (8.2) 75 4 (4) −0·10 (−0·024 to
−0·04)
Khoury 2018 Missed laboratory
tests (at 12mths)
72 16 (13.8) 75 14 (18) −0·10 (−0·20 to 0·18)
Khoury 2018 Changes in medica-
tion (at 12 mths)
72 6.8% 75 20.6% p<0.001
Khoury 2018 Disease activity at
12mths (Psoriasis
Area and Severity In-
dex - PASI)
72 0.1 (SE+/-0.2) 75 -0.16 (SE+/-0.2) −0·24, (−0·84 to 0·36)
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Analysis 1.18.   Comparison 1 Patient-initiated appointment systems versus consultant-
led appointment systems, Outcome 18 Rheumatoid arthritis: other outcomes.











P value (95% CI)
Fredriksson 2016 Confidence in care
at 18 months (VAS 1–
100 mm)
64 1 (–2 to 7) 67 0 (–4 to 7) 0.97
Fredriksson 2016 General health at 18
months (VAS 1–100
mm)
64 –1 (–12 to 8) 67 –4 (–17 to 9) 0.57
Fredriksson 2016 Number swollen
joints at 18 months
64 –3 (–5 to 0) 67 –1 (–3 to 1) 0.40
Fredriksson 2016 Number of tender
joints at 18 months
64 –1 (–4 to 0) 67 –1 (–3 to 0) 0.81
Fredriksson 2016 Cases where treat-
ment was changed
at 18 months (%)
64 68 67 48 0.0002
Fredriksson 2016 C-reactive protein
(mg/L) at 18 months
64 0 (–2 to 1) 67 0 (–3 to 1) 0.70
Fredriksson 2016 Erythrocyte sedi-
mentation rate (mm/
hour) at 18 months
64 4 (–2 to 10) 67 0 (–4 to 5) 0.03
Hewlett 2000 Helplessness (AHI
0–30) at 48 months
(mean difference
from baseline)
74 –0.2 60 1.0 ns
Hewlett 2000 Confidence with
intervention at 48
months (VAS 1–10)
74 0.5 60 –0.6 < 0.01
Hewlett 2000 — — — — — —
Hewlett 2000 — — — — — —
Hewlett 2000 — — — — — —
Hewlett 2000 — — — — — —
Hewlett 2000 — — — — — —
 
 
Analysis 1.19.   Comparison 1 Patient-initiated appointment systems versus










P value (95% CI)
Lahdensuo 1996 Lung function 56 NR 59 NR ns
Lahdensuo 1996 Days oH work 56 2.8 (0–62) 59 4.8 (0–27) 0.02
 
 
A P P E N D I C E S
Appendix 1. Search strategies
Database: Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid MEDLINE(R) <1946 to Present>
1 (patient* adj3 initiate*).ti,ab.
2 (patient* adj3 led).ti,ab.
3 (patient* adj3 access*).ti,ab.
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10 same day schedule*.ti,ab.
11 shared care.ti,ab.
12 (patient* adj (choice or choosing)).ti,ab.
13 "out of hours".ti,ab.
14 Health Services Accessibility/og [Organization & Administration]
15 or/1-14
16 exp "Appointments and Schedules"/
17 appointment*.ti,ab.
18 (outpatient* or out patient*).ti,ab.
19 (clinic or clinics).ti,ab.
20 Outpatient Clinics, Hospital/
21 ((follow up* or followup*) and (visit* or consultation*)).ti,ab.
22 (check up* or checkup*).ti,ab.
23 secondary care.ti,ab.
24 or/16-23
25 15 and 24
26 (patient* schedule* adj (appointment* or visit* or follow up)).ti,ab.
27 (same day adj (appointment* or visit* or schedule*)).ti,ab.
28 (open access adj (appointment* or visit* or schedule*)).ti,ab.
29 (patient adj3 access* adj3 (follow up* or visit* or appointment*)).ti,ab.
30 (demand based adj (scheduling or appointment* or visit* or follow up)).ti,ab.
31 advanced access scheduling.ti,ab.
32 (patient initiated adj3 (follow up* or appointment*)).ti,ab.
33 or/26-32
34 25 or 33
Database: Embase <1974 to Present>
1 (patient* adj3 initiate*).ti,ab.
2 (patient* adj3 led).ti,ab.
3 (patient* adj3 access*).ti,ab.
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10 same day schedule*.ti,ab.
11 shared care.ti,ab.
12 (patient* adj (choice or choosing)).ti,ab.
13 "out of hours".ti,ab.
14 or/1-13
15 appointment*.ti,ab.
16 (outpatient* or out patient*).ti,ab.
17 (clinic or clinics).ti,ab.
18 ((follow up* or followup*) and (visit* or consultation*)).ti,ab.
19 (check up* or checkup*).ti,ab.
20 secondary care.ti,ab.
21 or/15-20
22 14 and 21
23 (patient* schedule* adj (appointment* or visit* or follow up)).ti,ab.
24 (same day adj (appointment* or visit* or schedule*)).ti,ab.
25 (open access adj (appointment* or visit* or schedule*)).ti,ab.
26 (patient adj3 access* adj3 (follow up* or visit* or appointment*)).ti,ab.
27 (demand based adj (scheduling or appointment* or visit* or follow up)).ti,ab.
28 advanced access scheduling.ti,ab.
29 (patient initiated adj3 (follow up* or appointment*)).ti,ab.
30 or/23-29
31 22 or 30
Database: PsycINFO <1806 to Present>
1 (patient* adj3 initiate*).ti,ab.
2 (patient* adj3 led).ti,ab.
3 (patient* adj3 access*).ti,ab.
4 (patient* adj3 request*).ti,ab.
5 self refer*.ti,ab.
6 open access*.ti,ab.
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10 same day schedule*.ti,ab.
11 shared care.ti,ab.
12 (patient* adj (choice or choosing)).ti,ab.
13 "out of hours".ti,ab.
14 or/1-13
15 appointment*.ti,ab.
16 (outpatient* or out patient*).ti,ab.
17 (clinic or clinics).ti,ab.
18 clinics/
19 ((follow up* or followup*) and (visit* or consultation*)).ti,ab.
20 (check up* or checkup*).ti,ab.
21 secondary care.ti,ab.
22 or/15-21
23 14 and 22
24 (patient* schedule* adj (appointment* or visit* or follow up)).ti,ab.
25 (same day adj (appointment* or visit* or schedule*)).ti,ab.
26 (open access adj (appointment* or visit* or schedule*)).ti,ab.
27 (patient adj3 access* adj3 (follow up* or visit* or appointment*)).ti,ab.
28 (demand based adj (scheduling or appointment* or visit* or follow up)).ti,ab.
29 advanced access scheduling.ti,ab.
30 (patient initiated adj3 (follow up* or appointment*)).ti,ab.
31 or/24-30
32 23 or 31
CDSR and CENTRAL
#1 (patient* near/3 initiate*):ti,ab
#2 (patient* near/3 led):ti,ab
#3 (patient* near/3 access*):ti,ab
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#9 unscheduled:ti,ab
#10 "same day schedule*":ti,ab
#11 "shared care":ti,ab
#12 (patient* next (choice* or choosing)):ti,ab
#13 "out of hours":ti,ab
#14 MeSH descriptor: [Health Services Accessibility] this term only
#15 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14
#16 MeSH descriptor: [Appointments and Schedules] explode all trees
#17 appointment*:ti,ab
#18 (outpatient* or "out patient"):ti,ab
#19 (clinic or clinics):ti,ab
#20 MeSH descriptor: [Outpatient Clinics, Hospital] explode all trees
#21 (("follow up*" or followup*) and (visit* or consultation*)):ti,ab
#22 ("check up*" or checkup*):ti,ab
#23 "secondary care":ti,ab
#24 #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23
#25 #15 and #24
#26 ("patient* schedule*" next (appointment* or visit* or "follow up")):ti,ab
#27 ("same day" next (appointment* or visit* or schedule*)):ti,ab
#28 ("open access" next (appointment* or visit* or schedule*)):ti,ab
#29 ((patient near/3 access*) near/3 ("follow up*" or visit* or appointment*)):ti,ab
#30 ("demand based" next (scheduling or appointment* or visit* or "follow up")):ti,ab
#31 "advanced access scheduling":ti,ab
#32 ("patient initiated" near/3 ("follow up*" or appointment*)):ti,ab
#33 #26 or #27 or #28 or #29 or #30 or #31 or #32
#34 #25 or #33
HMIC Health Management Information Consortium <1979 to Present>
1 (patient* adj3 initiate*).ti,ab.
2 (patient* adj3 led).ti,ab.
3 (patient* adj3 access*).ti,ab.
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9 unscheduled.ti,ab.
10 same day schedule*.ti,ab.
11 shared care.ti,ab.
12 (patient* adj (choice or choosing)).ti,ab.
13 "out of hours".ti,ab.
14 or/1-13
15 appointment*.ti,ab.
16 (outpatient* or out patient*).ti,ab.
17 (clinic or clinics).ti,ab.
18 Outpatient Clinics, Hospital/
19 ((follow up* or followup*) and (visit* or consultation*)).ti,ab.
20 (check up* or checkup*).ti,ab.
21 secondary care.ti,ab.
22 or/15-21
23 (patient* schedule* adj (appointment* or visit* or follow up)).ti,ab.
24 (same day adj (appointment* or visit* or schedule*)).ti,ab.
25 (open access adj (appointment* or visit* or schedule*)).ti,ab.
26 (patient adj3 access* adj3 (follow up* or visit* or appointment*)).ti,ab.
27 (demand based adj (scheduling or appointment* or visit* or follow up)).ti,ab.
28 advanced access scheduling.ti,ab.
29 (patient initiated adj3 (follow up* or appointment*)).ti,ab.
30 or/23-29
31 14 and 22
32 30 or 31
CINAHL via EBSCOhost
 
S45 S28 OR S44
S44 S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S36 OR S37 OR S40 OR S41 OR S43
S43 AB ("patient initiated" and (follow*up* or appointment*))
S42 TI ("patient initiated" and (follow*up* or appointment*))
S41 AB ("advanced access scheduling")
S40 TI ("advanced access scheduling")
S39 AB ("demand based" and (scheduling or appointment* or visit* or follow*up*))
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S38 TI ("demand based" and (scheduling or appointment* or visit* or follow*up*))
S37 AB ("patient* access*" and (follow*up* or visit* or appointment*))
S36 TI (patient* and access* and (follow*up* or visit* or appointment*))
S35 TI (patient* N3 access*) and TI (follow*up* or visit* or appointment*))
S34 AB ("open access" AND (appointment* or visit* or schedule*))
S33 TI ("open access" AND (appointment* or visit* or schedule*))
S32 AB ("same day" and (appointment* or visit* or schedule*))
S31 TI ("same day" and (appointment* or visit* or schedule*))
S30 AB ("patient schedule*" AND (appointment* or visit* or follow*up))
S29 TI ("patient schedule*" AND (appointment* or visit* or follow*up))
S28 S17 AND S27
S27 S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26
S26 TI secondary care OR AB secondary care
S25 TI ( checkup* or "check up*" ) OR AB ( checkup* or "check up*" )
S24 AB ( "follow up*" or followup* ) AND AB ( visit* or consultation* )
S23 TI ( "follow up*" or followup* ) AND TI ( visit* or consultation* )
S22 (MM "Outpatient Service/AM/OG/UT")
S21 TI ( clinic or clinics ) OR AB ( clinic or clinics )
S20 TI ( outpatient* or "out patient*" ) OR AB ( outpatient* or "out patient*" )
S19 TI appointment* OR AB appointment*
S18 (MM "Appointments and Schedules")
S17 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR
S15 OR S16
S16 (MM "Health Services Accessibility/AM/EV/UT")
S15 (MM "Direct Access")
S14 TI "out of hours" OR AB "out of hours"
S13 TI "patient* choosing*" OR AB "patient* choosing*"
S12 TI "patient* choice*" OR AB "patient* choice*"
S11 TI "shared care" OR AB "shared care"
  (Continued)
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S10 TI "same day schedule*" OR AB "same day schedule*"
S9 TI unscheduled OR AB unscheduled
S8 TI advanced access* OR AB advanced access*
S7 TI direct access* OR AB direct access*
S6 TI open access* OR AB open access*
S5 TI self refer* OR AB self refer*
S4 TI patient* N3 request* OR AB patient* N3 request*
S3 TI patient* N3 access* OR AB patient* N3 access*
S2 TI patient* N3 led OR AB patient* N3 led
S1 TI patient* N3 initiate* OR AB patient* N3 initiate*
  (Continued)
 
ProQuest Dissertations & Theses Global
(ti,ab("patient* schedule*" NEAR/4 (appointment* OR visit* OR "follow up*")) OR ti,ab("same day" NEAR/4 (appointment* OR visit*
OR schedule*)) OR ti,ab("open access" NEAR/4 (appointment* OR visit* OR schedule*)) OR ti,ab(patient* NEAR/3 access* NEAR/3
(appointment* OR visit* OR "follow up*")) OR ti,ab("demand based" NEAR/4 (scheduling OR appointment* OR visit* OR "follow up*"))
OR ti,ab("advanced access scheduling") OR ti,ab("patient initiated" NEAR/3 ("follow up*" OR appointment*))) OR ((ti,ab(patient* NEAR/3
initiate*) OR ti,ab(patient* NEAR/3 led*) OR ti,ab(patient* NEAR/3 access*) OR ti,ab(patient* NEAR/3 requested) OR ti,ab("self refer*")
OR ti,ab("open access*") OR ti,ab("direct access*") OR ti,ab("advanced access*") OR ti,ab(unscheduled) OR ti,ab("shared care") OR
(ti,ab(patient* NEAR/4 choice) OR ti,ab(patient* NEAR/4 choosing)) OR ti,ab("out of hours")) AND (ti,ab(appointment*) OR ti,ab(outpatient*
OR "out patient*") OR ti,ab(clinic OR clinics) OR (ti,ab("follow up*" OR followup*) AND ti,ab(visit* OR consultation*)) OR ti,ab("check up*"
OR checkup*) OR ti,ab("secondary care")))
ClinicalTrials.gov
“patient initiated” or Open access appointments or “Open access” and clinics or “open access”
International Clinical Trials Registry Platform (ICTRP)
Patient initiated or open access
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Study design (e.g. RT, cluster-RCT):








Telephone contact: Yes No Safety net review: Yes No
Describe: Describe:








Consultant led: Yes No Appointment schedule:  
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No. lost to follow-up
Age (mean SD)
Male/Female




RISK OF BIAS (low risk, high risk, unclear)
Random sequence generation  
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Blinding of participants and personnel  
Notes:
Blinding of outcome assessment  
Notes:










Appendix 3. GRADE summary table
Author(s):
Date:
Question: Patient initiated appointment systems compared to consultant-led appointments for managing care for people with chronic
conditions in secondary care
Setting: secondary care (hospital outpatient care)
Bibliography:
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5 Randomised trials Seriousa Not seri-
ous
Not serious Seriousb None –/0 — OR 0.87
(0.68 to
1.12)
1 fewer per 1000





6 Randomised trials Seriousa Not seri-
ous
Not serious Seriousb None –/0 –/0 OR 0.79
(0.51 to
1.23)
1 fewer per 1000





7 Randomised trials Serious Not seri-
ous
Not serious Seriousc None 707 779 — SMD 0.12 higher
(0.01 lower to 0.24 higher)
⊕⊕⊝⊝ Low —
Service utilisation (contacts)




None — — — 0 





8 Randomised trials Seriousa Seriouse Not serious Seriousd,e None — — — 0 





12 Randomised trials Seriousa Seriousf Not serious not seri-
ous
None — — — 0 

























































































































































4 Randomised trials Not seri-
ousa
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CI: confidence interval; HADS: Hospital Anxiety and Depression Scale; OR: odds ratio; SMD: standardised mean diHerence.
Explanations
aRisk of bias reporting is largely unclear.
bWide confidence intervals for all studies.
cSMD point is quite variable and some with wide confidence intervals.
dContact with diHerent services reported diHerently.
eWide ranging costs of services reported but partly due to wide range of contacts reported.
fSatisfaction was reported diHerently across studies.
gRelapse considered and reported diHerently across conditions.
hVery few studies reported relapse.
C O N T R I B U T I O N S   O F   A U T H O R S
RW: conceiving, designing and co-ordinating protocol; screening search results and retrieved papers against eligibility criteria; appraising
quality of papers and data extraction; analysis and interpretation of data; data management and writing up final review.
JTC: conceiving, designing and co-ordinating protocol; informing search strategies; screening search results and retrieved papers against
eligibility criteria; appraising quality of papers; extracting data; analysis and interpretation of data; providing comments on final review.
MR: designing protocol; led design of search strategies and literature search; helped with document retrieval; writing and editing parts of
final review.
RA: editing protocol; screening search results and retrieved papers against eligibility criteria; appraising quality of papers; extracting data;
data management; editing final review.
LA: screening search results; checking retrieved papers against eligibility criteria; appraising quality of papers; extracting data; data
management; checking data inputting in Review Manager 5.
OU: designing statistical methods of the protocol; analysis and interpretation of final review from a methodological perspective; editing
final review.
JM: analysis and interpretation of final review; editing final review.
VG: screening search results; checking retrieved papers against eligibility criteria; appraising quality of papers; editing final review.
SB: screening search results; retrieved papers from update search against eligibility criteria; appraising quality of papers; extracting data
as necessary; editing final review.
MP: conceiving and designing protocol; determining search strategies; interpreting data from a clinical and policy perspective; involved
in writing final review.
KS: conceiving, designing and co-ordinating protocol; interpretation of data in final review; providing a methodological and policy
perspective within writing up and giving advice on review; securing funding for review.
D E C L A R A T I O N S   O F   I N T E R E S T
RW: has been involved in a related review that has been published.
JTC: has been involved in a related review that has been published.





VG: implemented a patient-initiated appointment system for people with rheumatoid arthritis at Plymouth Healthcare NHS Trust which
has been published.
SB: none.
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MP: implemented a patient-initiated appointment system for people with rheumatoid arthritis at Plymouth Healthcare NHS Trust which
has been published. Has been involved in a related review that has been published.
KS: has been involved in a related review that has been published.
S O U R C E S   O F   S U P P O R T
Internal sources
• No sources of support supplied
External sources
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This systematic review will be funded by the National Institute for Health Research (NIHR) through Peninsula CLAHRC. This review will
present independent research commissioned by the NIHR. The views expressed in this publication are those of the author(s) and not
necessarily those of the National Health Service, the NIHR or the Department of Health.
D I F F E R E N C E S   B E T W E E N   P R O T O C O L   A N D   R E V I E W
Simon Briscoe, Lindsey Anderson, Vicki Goodwin and Justin Matthews were added to the review aOer registration of the protocol (Whear
2013). Their contributions are detailed in Contributions of authors.
Service utilisation (contacts) and resource use as described in the protocol have been relabelled for consistency as service utilisation
(contacts and costs).
We conducted two outcome analyses using a fixed-eHect model rather than a random-eHects model as the two studies and the outcomes
included in these analyses were so similar, making the fixed-eHect model more appropriate.
We had planned to present the risk ratios of any dichotomous data, but were unable to do so due to the data being mixed dichotomous
and continuous data.
For the meta-analyses, we used the most common/nearest reported time point across studies to combine data.
We did not assess reporting bias due to the low numbers of studies in the meta-analyses.
We only conducted a subgroup analysis by health condition for the outcomes that had three or more studies with useable data (anxiety,
depression and quality of life). We were unable to conduct a subgroup analysis based on age.
The studies did not report clinician satisfaction. The review authors decided not to include this outcome as a separate row in the 'Summary
of findings' table (contrary to the protocol), but have included it in the comments.
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